latest biotechnology research papers

More From Forbes

18 new and emerging biotech developments everyone should know about.

• Share to Facebook
• Share to Twitter
• Share to Linkedin

Biotechnology comprises the study and manipulation of living organisms with the goal of creating new products and processes that can improve our health and/or standards of living. It’s a field that can lead to revolutionary new developments in everything from healthcare to food production to waste management.

Major happenings in the biotech industry can have a significant impact on humanity, the Earth and the animal kingdom, so it’s not surprising that headlines from the field are of immense interest to tech experts and the general public alike. Below, 18 members of Forbes Technology Council discuss some of the amazing new and emerging biotech tools and developments everyone should know about and why they’re so exciting.

1. Brain Mapping

In 2021, Google and Harvard announced they had mapped the equivalent of a 1-millionth section of the human brain. The resulting map took up 1.4 petabytes of disk space, comparable in size to three decades’ worth of satellite images of Earth. Once technology advances and allows us to map larger areas of the human brain, we will better understand and be able to help those with traumatic injuries or neurological disorders and diseases. - Joe McCunney , Scalar Labs

2. Autonomous Therapeutic Systems

Autonomous therapeutic systems are one of the most significant future medical technologies. These systems take over patient care from (human) providers by analyzing, determining and autonomously controlling conditions and treatments. Thus, we need to have a precise simulation of a patient’s medical condition—the patient’s bio digital twin. This should reduce human error and medical care costs. - Kazuhiro Gomi , NTT Research

Forbes Technology Council is an invitation-only community for world-class CIOs, CTOs and technology executives. Do I qualify?

3. AlphaFold

AlphaFold is a protein folding program developed by Google’s DeepMind. It’s a major breakthrough in the field of protein folding. By understanding how proteins fold, we can better understand how they work and how they can be manipulated to improve human health. Additionally, we can more quickly design better drugs that will bind to their targets with greater specificity and affinity. - Sandeep Singh , Beans.AI

4. Cellular Anti-Aging Research

One of the biggest areas of biotech research right now is anti-aging at the cellular level. Researchers believe that we can actually reverse aging, which could not only help people live longer, but could also provide cures or treatments for diseases that are incurable today. There are ethical issues to be worked out, but the potential to change life as we know it is exciting. - Lior Yaari , Grip Security

5. CRISPR-Based Gene Editing

One thrilling biotech breakthrough is CRISPR-based gene editing. This technique allows precise modifications to DNA, offering potential cures for genetic disorders. For the general public, the implications are vast, including everything from addressing inheritable diseases to revolutionizing agriculture. Imagine a future where we could eliminate conditions such as cystic fibrosis or grow drought-resistant crops. - Miguel Llorca , Torrent Group

6. Microbiome Manipulation

Manipulation of the microbiome is exciting everyone. The study of the numerous microbes that reside within our bodies indicates that their impact on our health extends beyond digestion. Leveraging this understanding has the potential to pave the way for personalized treatments targeting a range of conditions, from obesity to mental health, thereby opening novel pathways toward enhanced well-being. - Jagadish Gokavarapu , Wissen Infotech

7. Living Medicines

An exciting but less talked-about area in biotech is living medicines. Imagine taking a pill filled with good bacteria that’s been programmed to fight your specific illness. These bacteria could sense what’s wrong in your body and release medicine only when needed. This could be a game-changer for treating chronic conditions. But, as with any new tech, it also raises questions about long-term safety. - Margarita Simonova , ILoveMyQA

8. Lab-Grown Organs

One of the most exciting developments in biotech has been the creation of lab-grown organs. Using a patient’s own cells, scientists can now cultivate organs in the lab that could potentially replace damaged ones, eliminating the need for organ donors and reducing the risk of organ rejection. This could revolutionize transplant medicine. - Sandro Shubladze , Datamam

9. Epigenetics And Digital Therapeutics

Epigenetics and digital therapeutics represent groundbreaking frontiers in biotech that would be of mass interest. Epigenetics offers transformative potential for personalized, precision medicine, tailoring treatments to individual genetic profiles. Concurrently, digital therapeutics herald a new era of holistic wellness, integrating technology for enhanced healing outcomes. - Rashmi Rao , RCubed Ventures

10. Sophisticated Wearables

The convergence of artificial intelligence and biotech has given rise to highly sophisticated wearables that do more than just count steps or monitor your heart rate. These devices are becoming capable of diagnosing conditions ranging from sleep apnea to cardiac arrhythmias—all in real time. The beauty of this trend is how accessible it is; you don’t need to be in a hospital to be closely monitored. - Marc Fischer , Dogtown Media LLC

11. Bioluminescent Imaging

Bioluminescent imaging, explored since the ’90s, is gaining renewed traction. It allows for real-time visualization of cellular processes in living organisms by making them glow! Imagine watching how a drug travels and affects different parts of a live organism. This could offer invaluable insights into drug effects and disease progression. - Andres Zunino , ZirconTech

12. Brain-Computer Interfaces

While still a decade away, brain-computer interfaces have the potential to revolutionize the way we learn, work and communicate. The advances in non-intrusive BCIs by a company called Neurable are going to do for cognitive monitoring what the Apple Watch did for cardio health. Consumers will no longer need electrodes and swim caps to monitor their brain health—just Neurable-compatible headphones. - Gentry Lane , ANOVA Intelligence

13. Lab-Grown Meats

Lab-grown or cultured meat is produced directly from animal cells without traditional animal farming. This can potentially address issues related to animal welfare, environmental sustainability and food security. It could significantly reduce the environmental impact of meat production while providing a more ethical and efficient way to meet the growing global demand for protein. - Cristian Randieri , Intellisystem Technologies

14. Organoid Intelligence

Organoid intelligence is a fascinating field, albeit far-reaching and difficult for a non-scientist to imagine as a reality. While AI aims to make computers more brain-like, OI research works to make a 3D brain cell culture more “computer-like” by giving it more inputs and outputs to “think.” Envision a future of brain-machine interfaces and biological computing. - Paula Kennedy Garcia , IntouchCX

15. 3D Bioprinting

3D bioprinting enables scientists to craft three-dimensional biological structures using living cells. This breakthrough could revolutionize organ transplants by offering patient-specific organs, drastically reducing waitlists. Additionally, it holds immense potential in reshaping personalized medicine and precise drug testing. - Amitkumar Shrivastava , Fujitsu

16. Plastic-Eating Bacteria

Scientists have recently engineered bacteria to “eat” plastic waste, addressing one of the planet’s most pressing environmental concerns. These modified bacteria can degrade plastics much faster than natural processes, potentially revolutionizing waste management and significantly reducing pollution. This breakthrough shows how solutions inspired by nature can rise to meet global challenges. - Marc Rutzen , HelloData.ai

17. Generative AI

For biotech companies, generative AI can improve the pace of innovation and improve efficiencies while providing better guardrails for privacy, security and compliance. Generative models trained on biotech content can be augmented with specific private project or company content, automated to carry out validation checks to ensure content compliance (such as not including any personally identifiable information), and verified against specified checklists. - Amrit Jassal , Egnyte

18. Quantum Technology

Quantum may still be nascent, but it’s already showing incredible potential to transform biotech in areas such as drug discovery. Hybrid approaches, such as quantum machine learning, are being explored now for their ability to analyze biological data, identify potential drug targets and rapidly predict drug interactions. This could unlock new drug treatments for complex diseases such as cancer. - Jeff Wong , EY

• Editorial Standards
• Reprints & Permissions

An official website of the United States government

The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

• Publications
• Account settings

Preview improvements coming to the PMC website in October 2024. Learn More or Try it out now .

• Advanced Search
• Journal List
• Forensic Sci Int Synerg

Recent advances in forensic biology and forensic DNA typing: INTERPOL review 2019–2022

Associated data.

This review paper covers the forensic-relevant literature in biological sciences from 2019 to 2022 as a part of the 20th INTERPOL International Forensic Science Managers Symposium. Topics reviewed include rapid DNA testing, using law enforcement DNA databases plus investigative genetic genealogy DNA databases along with privacy/ethical issues, forensic biology and body fluid identification, DNA extraction and typing methods, mixture interpretation involving probabilistic genotyping software (PGS), DNA transfer and activity-level evaluations, next-generation sequencing (NGS), DNA phenotyping, lineage markers (Y-chromosome, mitochondrial DNA, X-chromosome), new markers and approaches (microhaplotypes, proteomics, and microbial DNA), kinship analysis and human identification with disaster victim identification (DVI), and non-human DNA testing including wildlife forensics. Available books and review articles are summarized as well as 70 guidance documents to assist in quality control that were published in the past three years by various groups within the United States and around the world.

1. Introduction

This review explores developments in forensic biology and forensic DNA analysis of biological evidence during the years 2019–2022. In some cases, there may be overlap with 2019 articles mentioned in the previous INTERPOL review covering 2016 to 2019 [ 1 ]. This review includes books and review articles, published guidance documents to assist in quality control, rapid DNA testing, using law enforcement DNA databases plus investigative genetic genealogy DNA databases along with privacy/ethical issues, forensic biology and body fluid identification, DNA extraction and typing methods, mixture interpretation involving probabilistic genotyping software (PGS), DNA transfer and activity level evaluations, next-generation sequencing (NGS), DNA phenotyping, lineage markers (Y-chromosome, mitochondrial DNA, X-chromosome), new markers and approaches (microhaplotypes, proteomics, and microbial DNA), kinship analysis and human identification with disaster victim identification (DVI), and non-human DNA testing including wildlife forensics.

Multiple searches, using the Scopus (Elsevier) and Web of Science (Clarivate) databases, were conducted in the first half of 2022 with “forensic” and “DNA” or “biology” and “2019 to 2022” as search options. Over 4000 articles were returned with these searches. Through visual examination of titles and authors, duplicates were removed, and articles sorted into 32 subcategories to arrive at a list of almost 2000 publications that were supplemented throughout the remainder of the year as this review was being prepared. The tables of contents for non-indexed journals, such as WIRES Forensic Science , Journal of Forensic Identification , and Forensic Genomics were also examined to locate potentially relevant articles.

For example, a Scopus search conducted on June 13, 2022, using “forensic DNA” and “2019 to 2022” found a total of 3059 documents. Table 1 lists the top ten journals from this search. The Forensic Science International: Genetics Supplement Series (see row #4 in Table 1 ) provides the proceedings of the International Society for Forensic Genetics (ISFG) meeting held in Prague in September 2019. This volume contains 914 pages with 347 articles (although only 172 showed up in the Scopus search) that are freely available at https://www.fsigeneticssup.com /[ 2 ]. Thus, searches conducted with one or even multiple databases (e.g., Scopus and Web of Science) may not be comprehensive or exhaustive.

Top ten journals with forensic DNA articles published from 2019 to 2022 based on a Scopus search on June 13, 2022.

1.1. Books, special issues, and review articles of note

Books published during the period of this review relating to forensic biology and forensic DNA include Essential Forensic Biology, Third Edition [ 3 ], Principles and Practices of DNA Analysis: A Laboratory Manual for Forensic DNA Typing [ 4 ], Forensic DNA Profiling: A Practical Guide to Assigning Likelihood Ratios [ 5 ], Forensic Practitioner's Guide to the Interpretation of Complex DNA Profiles [ 6 ], Silent Witness: Forensic DNA Evidence in Criminal Investigations and Humanitarian Disasters [ 7 ], Mass Identifications: Statistical Methods in Forensic Genetics [ 8 ], Probability and Forensic Evidence: Theory, Philosophy, and Applications [ 9 ], Interpreting Complex Forensic DNA Evidence [ 10 ], Understanding DNA Ancestry [ 11 ], Understanding Forensic DNA [ 12 ], and Handbook of DNA Profiling [ 13 ]. The 2022 Handbook of DNA Profiling spans two volumes and 1206 pages with 54 chapters from 115 contributors representing 17 countries.

Over the past three years, several special issues on topics related to forensic biology were published in Forensic Science International: Genetics and Genes . These special issues were typically collated virtually rather than physically as invited articles were published online over some period of time and then bundled together virtually as a special issue. Some of these review articles or a set of special issue articles are open access (i.e., the authors paid a publication fee so that the article would be available online for free to readers).

During the time frame of this INTERPOL DNA review, FSI Genetics published two special issues: (1) “Trends and Perspectives in Forensic Genetics” (editor: Manfred Kayser) 1 with nine review and two original research articles published between September 2018 and January 2019, and (2) “Forensic Genetics – Unde venisti et quo vadis?” [Latin for “where did you come from and where are you going?”] (editor: Manfred Kayser) with nine articles published in 2021 and early 2022 and likely two more before the end of 2022. Topics for review articles in these special issues include DNA transfer [ 14 ], probabilistic genotyping software [ 15 ], microhaplotypes in forensic genetics [ 16 ], investigative genetic genealogy [ 17 ], forensic proteomics [ 18 ], distinguishing male monozygotic twins [ 19 ], and using the human microbiome for estimating post-mortem intervals and identifying individuals, tissues, or body fluids [ 20 , 21 ]. All of these topics will be discussed later in this article.

A Genes special issue “Forensic Genetics and Genomics” (editors: Emiliano Giardina and Michele Ragazzo) 2 published 11 online articles plus an editorial from April 2020 to January 2021 while another Genes special issue “Forensic Mitochondrial Genomics” (editors: Mitch Holland and Charla Marshall) 3 compiled 11 articles from February 2020 to April 2021. An “Advances in Forensic Genetics” Genes special issue (editor: Niels Morling) 4 included 25 articles shared between April 2021 and May 2022. In July 2022, the Advances in Forensic Genetics articles were compiled as a 518-page book. 5 Other Genes special issues in development or forthcoming covering aspects of forensic DNA and requesting potential manuscripts by late 2022 or early 2023 include “State-of-the-Art in Forensic Genetics” (editor: Chiara Turchi), 6 “Trends in Population Genetics and Identification—Impact on Anthropology (editors: Antonio Amorim, Veronica Gomes, Luisa Azevedo), 7 “Identification of Human Remains for Forensic and Humanitarian Purposes: From Molecular to Physical Methods” (editors: Elena Pilli, Cristina Cattaneo), 8 “Improved Methods in Forensic and DNA Analysis” (editor: Marie Allen), 9 “Forensic DNA Mixture Interpretation and Probabilistic Genotyping” (editor: Michael Coble) 10 , and “Advances in Forensic Molecular Genetics” (editors: Erin Hanson and Claire Glynn). 11 There has been a proliferation of review articles and special issues in this field in the past several years!

A new journal Forensic Science International: Reports was launched in November 2019. As of June 2022, it has published 89 articles involving DNA, most of which are descriptions of population genetic data. Likewise, a June 27, 2022, PubMed search with “forensic DNA” and the journal “Genes” found 88 articles – many of which are part of the previously mentioned special issues.

1.2. Guidance documents

Numerous documentary standards and guidance documents related to forensic DNA have been published by various organizations around the world. Table 2 lists 70 such documents released in the past three years (2019–2022) in the United States, UK, Australia, and the European Union.

Guidance documents related to forensic DNA published from 2019 to 2022. The titles are hyperlinked to available documents. Abbreviations: FBI (Federal Bureau of Investigation), CODIS (Combined DNA Index System), SWGDAM (Scientific Working Group on DNA Analysis Methods), NGS (next generation sequencing), US DOJ (United States Department of Justice), ULTR (Uniform Language for Testimony and Reports), AABB (Association for the Advancement of Blood and Biotherapies), ASB (Academy Standards Board), OSAC (Organization of Scientific Area Committees for Forensic Science), UKFSR (United Kingdom Forensic Science Regulator), ENFSI (European Network of Forensic Science Institutes), NIFS (National Institute of Forensic Science), ISFG (International Society for Forensic Genetics).

1.2.1. SWGDAM, FBI, and other US DOJ activities

The Federal Bureau of Investigation (FBI) Laboratory funds the Scientific Working Group on DNA Analysis Methods (SWGDAM) 12 to serve as a forum for discussing, sharing, and evaluating forensic biology methods, protocols, training, and research. In addition to creating guidelines on various topics, SWGDAM, which meets semiannually in January and July, provides recommendations to the FBI Director on the Quality Assurance Standards (QAS) used to assess U.S. forensic DNA laboratories involved in the National DNA Index System (NDIS) that perform DNA databasing and forensic casework. New versions of the QAS became effective July 1, 2020.

SWGDAM work products from the timeframe of 2019–2022 (see Table 2 ) include QAS audit and guidance documents, mitochondrial DNA analysis and short tandem repeat (STR) interpretation guideline revisions related to next-generation sequencing (NGS), training and Y-chromosome interpretation guidelines, a Y-chromosome Haplotype Reference Database (YHRD) update for U.S. laboratories, and reports on investigative genetic genealogy and Y-screening of sexual assault evidence kits. These documents are all accessible online. 13

In January 2022, the FBI produced a 13-page guide 14 on rapid DNA testing describing booking station applications and their vision for future integration of crime scene sample analysis and the Combined DNA Index System (CODIS), which builds on a joint position statement published in July 2020 by leaders of U.S. and European groups [ 22 ]. In addition, the FBI has shared guidance on their website for non-CODIS use of rapid DNA testing with law enforcement applications 15 and considerations for court. 16

United States Department of Justice (US DOJ) Uniform Language for Testimony and Reports (ULTRs), 17 contain three ULTRs for the forensic DNA discipline that became effective in March 2019: autosomal DNA with probabilistic genotyping, mitochondrial DNA, and Y-STR DNA. USDOJ also released an interim policy on investigative genetic genealogy in November 2019 [ 23 ] along with an opinion piece in the journal Science calling for responsible genetic genealogy [ 24 ].

Other agencies within US DOJ, namely the Bureau of Justice Assistance (BJA) and the National Institute of Justice (NIJ), published a guide for prosecutors on triaging forensic evidence [ 25 ] and best practices for improving DNA laboratory process efficiency [ 26 ]. A 200-page report to Congress on the needs assessment of forensic laboratories and medical examiner/coroner offices was released in December 2019 calling for $640 million annually in additional funding to support U.S. forensic efforts [ 27 ].

In September 2021, the Forensic Technology Center of Excellence (FTCOE), which is funded by NIJ, published a 29-page implementation strategy on next-generation sequencing for DNA analysis that was written by the NIJ Forensic Laboratory Needs Technology Working Group (FLN-TWG) [ 28 ]. In May 2022, FTCOE released a 50-page landscape study examining technologies and automation for differential extraction and sperm separation used in sexual assault investigations [ 29 ]. An introduction to forensic genetic genealogy was released in September 2022 [ 30 ].

The FTCOE also published a human factors forensic science sourcebook 18 in March 2022 through open access articles in the journal Forensic Science International: Synergy . This sourcebook, which has general applicability rather than being specific to forensic DNA analysts, includes an overview article [ 31 ] along with articles on personnel selection and assessment [ 32 ], the benefits of committing errors during training [ 33 ], how characteristics of human reasoning and certain situations can contribute to errors [ 34 ], stressors that impact performance [ 35 ], and the impact of communication between forensic analysts and detectives using a new metaphor [ 36 ].

1.2.2. OSAC and ASB activities

The Organization of Scientific Area Committees for Forensic Science (OSAC) 19 is congressionally-funded and administered by the Special Programs Office within the National Institute of Standards and Technology (NIST). OSAC consists of a governing board and over 600 members and associates organized into seven scientific area committees (SACs) and 22 subcommittees. The Biology SAC is divided into human and wildlife forensic biology activities. The Human Forensic Biology Subcommittee 20 focuses on standards and guidelines related to training, method development and validation, data analysis, interpretation, and statistical analysis as well as reporting and testimony for human forensic serological and DNA testing. The Wildlife Forensics Subcommittee 21 works on standards and guidelines related to taxonomic identification, individualization, and geographic origin of non-human biological evidence based on morphological and genetic analyses.

The Academy Standards Board (ASB) 22 is a wholly owned subsidiary of the American Academy of Forensic Sciences (AAFS) and was established as a standards developing organization (SDO). In 2015, ASB was accredited as an SDO by the American National Standards Institute (ANSI). The ASB DNA Consensus Body, with a membership consisting of practitioners, researchers, and lawyers, develops standards and guidelines related to the use of DNA in legal proceedings. Many of the documents developed by ASB were originally proposed OSAC standards or guidelines.

The OSAC Registry 23 is a repository of high-quality and technically-sound standards (both published and proposed) that are intended for implementation in forensic science laboratories. As of July 2022, the OSAC Registry contains 11 standards published by ASB as well as two (2) proposed OSAC standards or best practice recommendations related to human forensic biology. Another four ASB standards and two proposed OSAC standards related to wildlife forensic biology are on the OSAC Registry. The ASB standards issued in the past three years related to human forensic biology cover interpretation and comparison protocols, training in various parts of the process, and validation of forensic serological and DNA analysis methods as well as probabilistic genotyping systems (see Table 2 for names of these documents). A number of other documents 24 related to serological testing methods, assigning propositions for likelihood ratios in forensic DNA interpretations, validation of forensic DNA methods and software, familial DNA searching, management and use of quality assurance DNA elimination databases, setting thresholds, evaluative forensic DNA testimony, and training in use of statistics are in development within OSAC and ASB.

Additional work products of OSAC include (1) a lexicon 25 with 3282 records (although multiple records may exist for the same word, e.g., there are five definitions provided for “validation” from various sources), (2) a 35-page technical guidance document 26 on human factors in validation and performance testing that describes key issues in designing, conducting, and reporting validation research, (3) a listing of research and development needs in forensic science 27 including 18 identified by the OSAC Human Forensic Biology Subcommittee during their deliberations ( Table 3 ), and (4) process maps for several forensic disciplines including a 42-page depiction of current practices and decisions in human forensic DNA analysis released in May 2022 [ 37 ]. As a visual representation of critical steps and decision points, a process map is intended to help improve efficiencies and reduce errors, and highlight gaps where further research or standardization would be beneficial. Process maps can assist with training new examiners and enable development of specific laboratory policies or help identify best practices for the field.

Research and development needs in forensic biology as identified by the OSAC Human Forensic Biology Subcommittee (as of July 2022, see https://www.nist.gov/osac/osac-research-and-development-needs ).

1.2.3. UK Forensic Science Regulator

The UK Forensic Science Regulator (UKFSR) oversees forensic science efforts in England, Wales, and Northern Ireland. In March 2021, the Regulator released the seventh issue 28 of the Codes of Practice and Conduct for forensic science providers and practitioners in the criminal justice system. This 114-page document, which has been updated every few years, provides the overall framework for forensic science activities in the UK with other supporting guidance documents on specific areas like DNA analysis or general tasks like validation. In September 2020, a number of the Regulator documents were revised and reissued. As noted in Table 2 (see rows with documents containing “Issue 1” in the title), new guidance documents were also released in the past few years on sexual assault examinations, development of evaluative opinions, proficiency testing for DNA mixture interpretation, Y-STR profiling, DNA relationship testing, and methods employing rapid DNA testing devices. Table 2 lists 20 guidance documents pertinent to forensic biology from the UKFSR.

1.2.4. European Union and Australia

The European Network of Forensic Science Institutes (ENFSI) DNA Working Group published two documents in the past three years: one on DNA database management and the other on training of staff in forensic DNA laboratories (see Table 2 ). A best practice manual for human forensic biology and DNA profiling is also under development.

The Australian National Institute of Forensic Science (NIFS) published three documents of relevance to forensic biology on case record review, empirical study design, and transitioning technology from the laboratory to the field (see Table 2 ).

1.2.5. Other international efforts

The Association for the Advancement of Blood and Biotherapies (AABB) 29 published the 15th edition of their Standard for Relationship Testing Laboratories, which became effective on January 1, 2022. This documentary standard was developed by the AABB Relationship Testing Standards Committee and applies to laboratories accredited for paternity testing and other forms of genetic relationship assessment.

The International Society for Forensic Genetics (ISFG) DNA Commission 30 published two articles during the timeframe of this INTERPOL review (see Table 2 ). In 2020, guidelines and considerations were published on evaluating DNA results under activity level propositions [ 38 ]. In addition, the state of the field regarding interpretation of Y-STR results was examined along with different approaches for haplotype frequency estimation using population data – with the Discrete Laplace approach being recommended [ 39 ]. Future ISFG DNA Commission efforts will address STR allele sequence nomenclature and phenotyping.

2. Advancements in current practices

This section (Section 2 ) is intended to be law enforcement and practitioner-focused through examination of advances in current practices. The following section (Section 3 ) is intended to be researcher-focused through emphasis on emerging technologies and new developments. In this section, topics specifically covered include rapid DNA analysis, use of DNA databases to aid investigations (including familial searching, investigative genetic genealogy, genetic privacy and ethical concerns, and sexual assault kit testing), body fluid identification, DNA extraction and typing methods, and DNA interpretation at the sub-source and activity level.

2.1. Rapid DNA analysis

Rapid DNA instruments that provide integrated “swab-in-profile-out” results in 90 min or less can be used in police booking station environments and assist investigations outside of a traditional laboratory environment. These instruments were initially designed for analysis of buccal swabs to help speed processing of reference samples associated with criminal cases. Such samples are expected to contain relatively large quantities of DNA from a single contributor. Some attempts to extend the range of sample types to low quantities of DNA or mixtures have been published with various levels of success (see Table 4 ). Researcher and practitioners from Australia [ [40] , [41] , [42] ], Canada [ 43 ], China [ 44 ], Italy [ 45 ], Japan [ 46 , 47 ], and the United States [ [48] , [49] , [50] , [51] , [52] , [53] , [54] , [55] , [56] , [57] ] have contributed to an increased understanding of rapid DNA testing capabilities and limitations.

Summary of 20 rapid DNA instrument validation and evaluation studies published from 2019 to 2022. Abbreviations: A-Chip (arrestee cartridge, designed for high-quantity DNA samples), I-Chip (investigative cartridge, designed for low-quantity DNA samples), ACE (arrestee cartridge with GlobalFiler STR markers), RapidINTEL (uses 32 rather than 28 PCR cycles to increase success with low-quantity DNA samples). A-Chip and I-Chip amplify the FlexPlex set of 23 autosomal STRs, three Y-STRs, and amelogenin [ 51 ]. ACE and RapidINTEL utilize the GlobalFiler set of 21 autosomal STRs, one Y-STR, one Y-chromosome InDel, and amelogenin.

The Accelerated Nuclear DNA Equipment (ANDE) 6C (ANDE, Longmont, CO, USA) and the RapidHIT ID (Thermo Fisher Scientific, Waltham, MA, USA) are the current 31 commercially available rapid DNA systems. Each system consists of a swab for introducing the sample, a cartridge or biochip with pre-packed reagents, the instrument, and analysis software with an expert system for automated STR allele calling. Different sample cartridges can be run on each system depending on the sample type and expected quantity of DNA.

For ANDE, the arrestee cartridge (A-Chip), can accommodate up to five samples and is intended for relatively high quantities of DNA typically collected from reference buccal swabs, while the investigative cartridge (I-Chip), can process up to four samples and is intended for lower quantities of DNA that might be present in casework or disaster victim identification samples. Both ANDE cartridges use the FlexPlex27 STR assay that tests 23 autosomal STR loci, three Y-chromosome STRs, and amelogenin to generate data compatible with DNA databases around the world [ 51 ]. The RapidHIT ID ACE cartridge and RapidINTEL cartridge serve similar purposes as the ANDE A-Chip and I-Chip using GlobalFiler Express kit markers (21 autosomal STRs, DYS391, a Y-chromosome insertion/deletion marker, and amelogenin) instead of the FlexPlex assay. The ACE sample cartridge uses buccal swabs while the EXT sample cartridge processes DNA extracts [ 56 ]. Sensitivity is enhanced in the RapidINTEL cartridge by increasing the number of PCR cycles from 28 to 32 and decreasing the lysis buffer volume from 500 μL to 300 μL compared to the ACE cartridge parameters [ 46 ].

With rapid DNA testing's swab-in and answer-out integrated configuration, limited options exist for testing conditions (e.g., either A-Chip or I-Chip with ANDE). Therefore, users should evaluate performance for the sample types they desired to routinely test in their specific environment. Table 4 summarizes recently published studies containing rapid DNA assessments.

National DNA Index System (NDIS) approval has been provided by the FBI Laboratory for accredited forensic DNA laboratories to use either the ANDE 6C or RapidHIT ID Systems (A-Chip and ACE cartridges only) 32 with eligible reference mouth swabs. As noted in Table 2 , the FBI.gov website contains three documents related to rapid DNA testing: “Non-CODIS Rapid DNA Considerations and Best Practices for Law Enforcement Use” (7-pages), “Rapid DNA Testing for Non-CODIS Uses: Considerations for Court” (5-pages), and “A Guide to All Things Rapid DNA” (13-pages) in January 2022 to provide information on the topic to law enforcement agencies.

The ENFSI DNA Working Group, SWGDAM, and an FBI Rapid DNA Crime Scene Technology Advancement Task Group co-published a position statement on the use of rapid DNA testing from crime scene samples [ 22 ]. These groups emphasized the need to have future rapid DNA systems with (1) methods to identify low quantity, degradation, and inhibition as well as meeting the human quantification requirements shared by SWGDAM and others, (2) the ability to export analyzable raw data for analysis or reanalysis by trained and qualified forensic DNA analysts, (3) an on-board fully automated expert system to accurately flag single-source or mixture DNA profiles requiring analyst evaluation, (4) improved peak height ratio balance (per locus and across loci) for low-quality and mixture samples “through enhancements in extraction efficiencies, changes in cycling parameters, and/or changes in STR kit chemistries,” and (5) published developmental validation studies on a wide variety of forensic evidence type samples with “data-supported recommendations regarding types of forensic evidence that are suitable and unsuitable for use with Rapid DNA technology” [ 22 ].

With a likely increase in the capabilities and the availability of rapid DNA systems, investigators will need to decide whether to use this capability onsite in specific situations or to send collected samples to a conventional forensic laboratory for processing at a later time. A group in the Netherlands collaborated with the New York City Police Department Crime Scene Unit and Evidence Collection Team to explore a decision support system [ 60 ]. In this study, participants were informed that rapid DNA testing was less sensitive compared to laboratory analysis and that the sample would be consumed, but that results from rapid DNA testing could identify a suspect within 2 h as opposed to waiting an average of 45 days for the laboratory results [presumably due to sample backlogs]. They were also told that a DNA profile obtained with rapid DNA would be acceptable in court. In the end, “>90% of the participants (85 out of 91) saw added value for using a Rapid DNA device in their investigative process …” with “a systematic approach, which consists of weighing all possible outcomes before deciding to use a Rapid DNA analysis device” [ 60 ]. The authors note that for such an approach to be successful “knowledge on DNA success rates [with various evidence types] is necessary in making evidence-based decisions for Rapid DNA analysis” [ 60 ].

A group in Australia performed a cost-benefit analysis of a decentralized rapid DNA workflow that might exist in the future with instruments placed at police stations around their country [ 61 ]. A virtual assessment considered all reference DNA samples collected during a two-month time period at 10 participating police stations in five regions of Australia. Processing times at the corresponding DNA analysis laboratories were calculated based on when the sample was received compared to the day when a DNA profile was obtained for that sample. From the survey conducted, it was estimated that up to 80,000 reference DNA samples are currently processed each year in forensic DNA laboratories across Australia [ 61 ].

Consumable costs for conventional DNA testing reagents in Australia were found to range from $17 to $35 whereas the rapid DNA consumable costs were estimated to be $100 per sample along with an anticipated $100,000 instrument cost per police station. Of course, the rate of use is expected to vary based on the number of reference samples collected in that jurisdiction. Since rapid DNA instruments utilize consumable cartridges with expiration dates, it was estimated that a police station would need to process six DNA samples per week to avoid having to discard an expired cartridge and thus increase the overall cost of their rapid DNA testing efforts. The authors of this study conclude “that routine laboratory DNA analysis meets the current needs for the majority of cases … It is anticipated that while the cost discrepancy between laboratory and rapid DNA processing remains high, the uptake of the technology in Australia will be limited [at least for a police booking station scenario]” [ 61 ].

Rapid DNA technology can be used in a variety of contexts including some that extend beyond traditional law enforcement. Seven distinct use contexts for rapid DNA capabilities have been described [ 62 ]: (1) evidence processing at or near crime scenes to generate leads for confirmation by a forensic laboratory, (2) booking or detection stations to compare an individual's DNA profile to a forensic database while the individual is still in custody, (3) disaster victim identification to permit rapid DNA processing of a victim's family members during their visit to family assistance centers when filing missing persons reports, (4) missing persons investigations to quickly process unidentified human remains and/or family reference samples to generate leads for confirmation by a forensic laboratory, (5) border security to develop DNA data from detainees for comparison to indices of prior border crossers while the individual is still in custody, (6) human trafficking and immigration fraud detection to permit immigration officials to verify family relationship claims, and (7) migrant family reunification to allow immigration officials to verify parentage claims and reunite family members separated at the border. Social and ethical considerations have been proposed for each of these use contexts in terms of data collection, data access and storage, and oversight and data protection [ 62 ].

One study [ 47 ] evaluating buccal swabs and mock disaster victim identification samples drew an important conclusion worth repeating here: “The Rapid DNA system provides robust and automated analysis of forensic samples without human review. Sample analysis failure can happen by chance in both the Rapid DNA system and conventional laboratory STR testing. While re-injection of PCR product is easily possible in the conventional method, this is not an option with the Rapid DNA system. Accordingly, the Rapid DNA system is a suitable choice but should be limited to samples that can easily be collected again if necessary or to samples that are of sufficient amount for repeated analysis. Application of this system to valuable samples such as those related to casework need to be considered carefully before analysis.”

2.2. Using DNA databases to aid investigations (national databases, familial searching, investigative genetic genealogy, genetic privacy & ethical concerns, sexual assault kit testing)

Forensic DNA databases can aid investigations by demonstrating connections between crime scenes, linking a previously enrolled DNA profile from an arrestee or convicted offender to biological material recovered from a crime scene, or aiding identification of missing persons through association of remains with biological relatives. Establishment of these databases requires significant investments over time to enroll data from crime scenes and potential serial offenders or unidentified human remains and relatives of missing persons. This section explores issues around national DNA databases, familial searching, investigative genetic genealogy, and genetic privacy and ethical concerns.

A systematic review regarding the effectiveness of forensic DNA databases looked at 19 articles published between 1985 and 2018 and found most studies support the assumption that DNA databases are an effective tool for the police, society, and forensic scientists [ 63 ]. Recommendations have been proposed to make cross-border exchange of DNA data more transparent and accountable with the Prüm system that enables information sharing across the European Union [ 64 ]. An analysis of news articles discussing the use of DNA testing in family reunification with migrants separated at the U.S.-Mexico border has been performed [ 65 ], and a standalone humanitarian DNA identification database has been proposed [ 66 ]. Aspects of international DNA kinship matching were explored to aid missing persons investigations and disaster victim identification processes [ 67 ]. A business case was presented for expanded DNA indirect matching using additional genetic markers, such as Y-chromosome STRs, mitochondrial DNA, and X-chromosome STRs, to reveal previously undetected familial relationships [ 68 ].

Approaches to transnational exchange of DNA data include (1) creation of an international DNA database, (2) linked or networked national DNA databases, (3) request-based exchange of data, and (4) a combination of these [ 69 ]. For example, the INTERPOL DNA database 33 contains more than 247,000 profiles contributed by 84 member countries. The I-Familia global database assists with missing persons identification based on international DNA kinship matching. 34

2.2.1. National DNA databases

Since the United Kingdom launched the first national DNA database in 1995, national DNA databases continue to be added in many countries including Brazil [ 70 , 71 ], India [ 72 ], Pakistan [ 73 , 74 ], Portugal [ 75 ], and Serbia [ 76 ]. A survey of 15 Latin American countries found that 13 of them had some kind of DNA database [ 77 ]. The opinions of 210 prisoners and prison officials in three Spanish penitentiary centers were also collected regarding DNA databases [ 78 ].

The effectiveness of databases has been debated over the years. Seven key indicators were used in a 2019 examination of the effectiveness of the UK national DNA database. These indicators included (1) implementation cost – the financial input required to implement the database system, (2) crime-solving capability – the ability of the database to assist criminal justice officials in case resolution, (3) incapacitation effect – the ability of the database to reduce crime through the incapacitation of offenders, (4) deterrence effect – the preventative potential of the database through deterrence of individuals from committing crime, (5) privacy protection – protection of the privacy or civil liberty rights of individuals, (6) legitimacy – compliance of the databasing system to the principle of proportionality, and (7) implementation efficiency – the time and non-monetary resource required to implement the database system [ 79 ].

A follow-up article concluded: “Available evidence shows that while DNA analysis has contributed to successful investigations in many individual cases, its aggregate value to the resolution of all crime is low” [ 80 ]. The systematic review of 19 articles on DNA databases cited previously noted “the expansion of DNA databases would only have positive effects on detection and clearance if the offender were already included in the database” [ 63 ]. When previous offenders are not already in a law enforcement DNA database to provide a hit to a crime scene profile, efforts are increasingly turning to familial searching and investigative genetic genealogy as described in the following sections.

2.2.2. Familial DNA searching

Familial DNA searching (FDS) extends the traditional direct matching of STR profiles within law enforcement databases to search for potential close family relationships, such as a parent or sibling, of a profile in the database. 35 FDS typically uses Y-STR lineage testing to narrow the set of candidate possibilities along with other case information such as geographic details of the crime and age of the person(s) of interest. For example, FDS helped solve murder cases in Romania [ 81 ] and China [ 82 ] by locating the perpetrator through a relative in the DNA database. A survey of 103 crime laboratories in the United States found that 11 states use FDS while laboratories in 24 states use a similar but distinct practice of partial matching [ 83 ].

The expansion of the number of STRs from 15 to 20 or 21 helps distinguish between true and false matches during a DNA database search by reducing the number of FDS adventitious matches [ 84 ]. Another study noted that the choice of allele frequencies affects the rate at which non-relatives are erroneously classified as relatives and found that using ancestry inference on the query profile can reduce false positive rates [ 85 ]. New Y-STR kits have been developed to assist with familial searching [ 86 , 87 ]. FDS of law enforcement databases differs from investigative genetic genealogy in two important ways – the genetic markers and the databases used for searching [ 88 , 89 ].

2.2.3. Investigative genetic genealogy

In recent years when national DNA databases fail to generate a lead to a potential person of interest, law enforcement agencies have started to utilize the capabilities of investigative genetic genealogy (IGG), also called forensic genetic genealogy (FGG) or forensic investigative genetic genealogy (FIGG), as an approach to locate potential persons of interest in criminal or missing persons cases. For example, a pilot case study in Sweden used IGG to locate the perpetrator of a double murder from 2004 who had evaded detection despite 15 years of various investigation efforts including more than 9000 interrogations and mass DNA screenings of more than 6000 men [ 90 ]. Hardly a week goes by without mention in the global media of another cold case being solved with IGG. Since the arrest of Joseph DeAngelo in April 2018 identified as the infamous Golden State Killer using IGG, hundreds of cold criminal and unidentified human remains cases have been resolved [ 91 ].

IGG involves examination of about 600,000 single nucleotide polymorphisms (SNPs), rather than the 20 or so STRs used in conventional forensic DNA testing, to enable associations of relatives as distant as third or fourth cousins [ 17 ]. IGG relies on a combination of publicly accessible records and the consent of individuals who have uploaded their genetic genealogy DNA profiles to genetic genealogy databases [ 92 ]. Multiple reviews and research articles have been published describing current IGG methods, knowledge, and practice along with the effectiveness and operational limits of the technique [ 17 , 30 , [93] , [94] , [95] , [96] , [97] ]. IGG works best with high-quality, single-source DNA samples. A case study involving whole genome sequencing of human remains from a 2003 murder victim found that it was possible to perform IGG for identification of the victim in this situation [ 98 ].

The four main direct-to-consumer (DTC) genetic genealogy companies, 23andMe (Mountain View, CA), Ancestry (Salt Lake City, UT), FamilyTree DNA (Houston, TX), and My Heritage (Lehi, UT), have DNA data from over 41 million individuals 36 as of July 2022 [ 97 ]. Individuals can upload their DTC data to GEDmatch, which is a DNA comparison and analysis website launched in 2010 and purchased in 2019 by Verogen (San Diego, CA). Law enforcement IGG searches are currently permitted with DTC data for individuals who opt into the GEDmatch database or do not opt out of the FamilyTree DNA database [ 99 , 100 ]. Currently most DTC genetic genealogy data comes from the United States and individuals of European origin. A UK study found that 4 of 10 volunteer donors could be identified with IGG including someone of Indian heritage demonstrating that under the right circumstances individuals of non-European origin can be identified [ 101 ].

As noted previously in Section 1.2.1 , the U.S. Department of Justice released an interim policy guide to forensic genetic genealogical DNA analysis and searching [ 23 ], and the FBI Laboratory's chief biometric scientist published an editorial in Science calling for responsible genetic genealogy [ 24 ]. SWGDAM has provided an overview of IGG that emphasizes the approach being used only after a regular STR profile search of a law enforcement DNA database fails to produce any investigative leads [ 102 ]. Policy and practical implications of IGG have been explored in Australia [ 103 ] and within the UK as part of probing the perceptions of 45 professional and public stakeholders [ 104 , 105 ].

Four misconceptions about IGG were examined by several members of the SWGDAM group: (1) when law enforcement conducts IGG in a genetic genealogy database, they are given special access to participants' SNP profiles, (2) law enforcement will arrest a genetic genealogy database participant's relatives based on the genetic information the participant provided to the database, (3) IGG necessarily involves collecting and testing DNA samples from a larger number of innocent persons than would be the case if IGG were not used in the investigation, and (4) IGG is or soon will be ubiquitous because there are no barriers to IGG that limit the cases in which it can be conducted [ 106 ].

In May 2021, the state of Maryland passed the first law in the United States and in the world that regulates law enforcement's use of DTC genetic data to investigate crimes. A policy forum article in Science explained how this new law provides a model for others in this area [ 107 ]. Six important features were described: (1) requiring judicial authorization for the initiation of an IGG search, (2) affirming individual control over the investigative use of one's genetic data, (3) establishing strong protections for third parties who are not suspects in the case, (4) ensuring that IGG is available to prove either guilt or innocence, (5) imposing consequences and fines for violations, and (6) requiring annual public reporting and review to enable informed oversight of IGG methods. However, as of September 2022, these regulations have not been implemented apparently due to lack of resources with these unfunded requirements. 37

Efforts have been made to raise awareness among defense attorneys about how IGG searches can potentially invade people's privacy in unique ways [ 108 ]. Important perspectives on ethical, legal, and social issues have been offered along with directions for future research [ 109 ]. These concerns about data privacy, public trust, proficiency and agency trust, and accountability have led to a call for standards and certification of IGG to address issues raised by privacy scholars, law enforcement agencies, and traditional genealogists [ 110 , 111 ] and for an ethical and privacy assessment framework covering transparency, access criteria, quality assurance, and proportionality [ 112 ].

2.2.4. Genetic privacy and ethical concerns

Two important topics are considered in this section: (1) do the genetic markers used in traditional forensic DNA typing reveal more than identity and therefore potentially impact privacy of the individuals tested? and (2) are samples collected and tested according to ethical principles?

Forensic DNA databases utilize STR markers that were intentionally selected to avoid phenotypic associations. An extensive review of the literature examined 107 articles associating a forensic STR with some genetic trait and found “no demonstration of forensic STR variants directly causing or predicting disease” [ 113 ]. A study of the potential association of 15 STRs and 3 facial characteristics on 721 unrelated Han Chinese individuals also found “scarcely any association between [the] STRs with studied facial characteristics” [ 114 ].

In 2021, the American Type Culture Collection (ATCC) published a standard for authentication of human cell lines using DNA profiling with the 13 CODIS STR markers [ 115 ]. This use of forensic STR markers for biospecimen authentication led a bioethicist and a law professor to write a policy forum article in Science titled “Get law enforcement out of biospecimen authentication” [ 116 ]. The authors of this policy forum believe that using the same genetic markers could potentially: (1) undermine efforts to recruit research participants from historically marginalized and excluded groups that are underrepresented in research, (2) risk drawing law enforcement interest in gaining access to these research data, and (3) impose additional potential harms on already vulnerable populations, particularly children. Instead they advocate for using non-CODIS STRs or a new SNP assay to distinguish biospecimens in repositories, something done recently at the Coriell Institute for Medical Research with six new STR markers [ 117 ]. A responsive letter to the editor regarding this policy forum article expressed that “their proposal could potentially create artificial silos between genomic data in the justice system and in biomedical research, making it inefficient and ultimately counterproductive” [ 118 ]. The authors of the original article responded that “the risk of attracting law enforcement interest to research data increases when the data are available in a recognizable way” [ 119 ].

Modern scientific research seeks to protect the dignity, rights, and welfare of research participants by following ethical requirements. Six forensic science journals over the time period of 2010–2019 were examined for their reporting of ethical approval and informed consent in original research using human or animal subjects [ 120 ]. These journals were Forensic Science International: Genetics , Science & Justice , Journal of Forensic and Legal Medicine , the Australian Journal of Forensic Sciences , Forensic Science International , and the International Journal of Legal Medicine . A total of 3010 studies that described research on human or animal subjects and/or samples were selected from these journals with only 1079 articles (36%) reporting that they had obtained ethical approval and 527 articles (18%) stating that informed consent was sought either by written or verbal agreement. The authors of this study noted that reported compliance with ethical guidelines in forensic science research and publication was below what is considered minimal reporting rates in biomedical research and encouraged widespread adoption of the 2020 guidelines described below [ 120 ].

Guidelines and recommendations for ethnical research on genetics and genomics of biological material were jointly adopted and published in Forensic Science International: Genetics [ 121 ] and Forensic Science International: Reports [ 122 ]. These guidelines utilize the following principles as prerequisites for publication in these two journals as well as the Forensic Science International: Genetics Supplement Series : (1) general ethics principles that are regulated by national boards and represent widely signed international agreements, (2) universal declarations that require implementations in state members, such as the World Medical Association Declaration of Helsinki biomedical research on human subjects, and (3) universal declarations and principles drafted by independent organizations that have been widely adopted by the scientific community. This includes the U.S. Federal Policy for the Protection of Human Subjects (“Common Rule”) that was revised in 2017 (with a compliance date delayed to January 21, 2019). 38

Submitted manuscripts must provide the following supporting documentation to demonstrate compliance with the publication guidelines: (1) ethical approval in the country of [sample] collection by the appropriate local ethical committee or institutional review board, (2) ethical approval in the country of experimental work according to local legislation; if material collection and experimentation are conducted in different countries, both (1) and (2) are required, (3) template of consent forms in the case of human material as approved by the relevant ethical committee, and (4) approved export/import permits as applicable. Authors must declare in their submitted manuscript that these guidelines have been strictly followed [ 121 , 122 ].

Forensic genetic frequency databases, such as the Y-chromosome Haplotype Reference Database (YHRD), have been challenged over the ethics of DNA holdings, specifically of samples originating from the minority Muslim Uyghur population in western China [ 123 , 124 ]. A survey of U.S. state policies on potential law enforcement access to newborn screening samples found that nearly one-third of states permit these samples or their related data to be disclosed to or used by law enforcement and more than 25% of states have no discernible policy in place regarding law enforcement access [ 125 ].

A framework for ethical conduct of forensic scientists as “lived practice” has been proposed, and three case studies were discussed in terms of decision-making processes involving forensic DNA phenotyping and biographical ancestry testing, investigative genetic genealogy, and forensic epigenetics [ 126 ]. An ethos for forensic genetics involving the values of integrity, trustworthiness, and effectiveness has likewise been described [ 127 ].

2.2.5. Sexual assault kit testing

Unsubmitted or untested sexual assault kits (SAKs) may exist in police or laboratory evidence lockers for many years leading to rape kit backlogs that can spark community outrage when discovered. A number of articles have been published in the past three years describing success rates with examining SAKs and the policies surrounding them. For example, an evaluation of 3422 unsubmitted SAKs in Michigan found 1239 that produced a DNA profile eligible for upload into CODIS with 585 yielding a CODIS hit [ 128 ]. In addition, results from a groping and sexual assault case were presented to support the expansion of touch DNA evidence in these types of cases [ 129 ].

To assess success rates in their jurisdiction, the Houston Police Department randomly selected 491 cases of over 6500 previously unsubmitted sexual assault kits [ 130 ]. Of these, 336 cases (68%; 336/491) screened positive for biological evidence; a DNA profile was developed in 270 cases (55%; 270/491) with 213 (43%; 213/491) uploaded to CODIS; and 104 (21% total; 104/491 or 49% of uploaded profiles; 104/213) resulted in a CODIS hit. The statute of limitation had expired in 44% of these CODIS-hit cases, which prohibited arrests and prosecution. Victims were unwilling to participate in a follow-up investigation in another 25% of these cases. When the data were compiled for the publication, charges had been filed in only one CODIS-hit case [ 130 ].

Sexual assault cases can be difficult to prosecute as victims may be re-traumatized when a cold case is reopened. The authors of one study shared: “A key to successful pursuit of cold case sexual assaults is to have a well-crafted victim-notification plan and a victim advocate as part of the investigative team” [ 131 ]. Interviews with eight assistant district attorneys provided important prosecutors’ perspectives on SAK cases, the development of narratives to explain the evidence in a case, and the decision on whether a case should be pursued or what further investigative activities may be needed [ 132 ]. The authors concluded: “Our findings suggest that forensic evidence does not magically lead to criminal justice outcomes by itself, but must be used thoughtfully in conjunction with other evidence as part of a well-considered strategy of investigation and prosecution” [ 132 ].

Discussing a data set from Denver, Colorado where 1200 sexual assault cold cases with testable DNA samples were examined and 600 cases were processed through the laboratory resulting in 97 CODIS hits, 55 arrests and court filings, and 48 convictions, the authors conclude that the cost of the Denver cold case sexual assault program was worth the investment [ 131 ].

From December 2015 to July 2018, the Palm Beach County Sheriff's Office (Florida, USA) researched more than 5500 cases and evaluated evidence from previously untested sexual assault kits spanning a 43-year period at a cost of over $1 million. Of the 1558 sexual assaults examined, there were 686 cases (44%; 686/1558) with CODIS-eligible profiles, 261 CODIS hits, and 5 arrests when the article was written in mid-2019 [ 133 ]. The Palm Beach County Sheriff's Office also helped develop a backlog reduction effort through creating a biological processing laboratory within the Boca Raton Police Services Department [ 134 ]. With this joint effort from 2016 to 2018, the total average turnaround time decreased from 30 days to under 20 days with the 3489 DNA profiles entered into CODIS resulting in 1254 associations and 965 investigations aided. Important takeaway lessons include the value of (1) engaging legal counsel early to outline necessary legal procedures and the timeline, (2) bringing all stakeholders “to the table” early to discuss expectations, as well as legal and operational responsibilities, and (3) creating a realistic timeline with a comprehensive memorandum of understanding so all parties have agreed to their roles and responsibilities [ 134 ].

From 275 previously untested sexual assault kits submitted for DNA testing in one region of Central Brazil, a total of 176 profiles were uploaded to their DNA database resulting in 60 matches (34%; 60/176) and 32 assisted investigations (18%; 32/176) with information about the suspect identity or the connection of serial sexual assaults assigned to the same individual [ 135 ]. Another study from the same region of Brazil examined 2165 cases and noted that 13% (286/2165) had information regarding the victim-offender relationship with 63% (179/286) being stranger-perpetrated rapes and 37% (107/286) being non-stranger [ 136 ]. The authors then summarize: “Hits were detected only with stranger-perpetrated assaults ( n  = 41), which reinforces that DNA databases are fundamental to investigate sexual crimes. Without DNA typing and DNA databases, probably these cases would never be solved” [ 136 ].

Given that laboratories have limited resources and need to prioritize their efforts, some business analytics have been applied to SAK testing. An analysis of the potential societal return on investment (ROI) for processing backlogged, untested SAKs reported a range of 10%–65% ROI depending on the volume of activity for the laboratory conducting the analysis [ 137 ]. An evaluation of data from 868 SAKs tested by the San Francisco Policy Department Criminalistics Laboratory during 2017–2019 found that machine learning algorithms outperformed forensic examiners in flagging potentially probative samples [ 138 ].

An examination of 5165 SAKs collected in Cuyahoga County (Ohio, USA) from 1993 through 2011 found 3099 with DNA of which 2127 produced a CODIS hit, with 803 investigations leading to an indictment and eventually 78 to trial along with 330 pleas [ 139 ]. The authors report a “cost savings to the community of $26.48 million after the inclusion of tangible and intangible costs of future sexual assaults averted through convictions” and advocate for “the cost-effectiveness of investigating no CODIS hit cases and support an ‘investigate all’ approach” [ 139 ]. Likewise an assessment of 900 previously-untested SAKs from Detroit (Michigan, USA) found that “few of the tested variables were significant predictors of CODIS hit rate” and “testing all previously-unsubmitted kits may generate information that is useful to the criminal justice system, while also potentially addressing the institutional betrayal victims experienced when their kits were ignored” [ 140 ].

A group in the Philippines described an integrated system to improve their SAK processing [ 141 ]. With an optimized workflow in Montreal, Canada, SAK processing median turnaround time decreased from 140 days to 45 days with a foreign DNA profile being obtained in 44% of cases [ 142 ]. In addition, this group examined casework data to guide resource allocation through identifying the likelihood of specific types of cases and samples yielding foreign biological material [ 142 ]. Decision trees and logistic regression models were also used to try and predict whether or not SAKs will yield a CODIS-eligible DNA profile [ 143 ]. Finally, direct PCR and rapid DNA approaches to streamline SAK testing were reviewed [ 144 ].

2.3. Forensic biology and body fluid identification

The basic workflow for biological samples in forensic examinations typically involves a visual examination of the evidence, a presumptive and/or confirmatory test for a suspected body fluid (e.g., the amylase assay for saliva), and DNA analysis and interpretation [ 145 ]. Body fluid identification (BFID), in particular with blood, saliva, semen, or vaginal fluid stains, provides valuable evidence in many investigations that can aid in the resolution of a crime [ 146 ]. Many of these BFID tests are presumptive and not nearly as sensitive as modern DNA tests meaning that “obtaining a DNA profile without being able to associate [it] with a body fluid is an increasingly regular occurrence” and “it is necessary and important, especially in the eyes of the law, to be able to say which body fluid that the DNA profile was obtained from” [ 147 ].

A number of approaches are being taken to improve the sensitivity and specificity of BFID in recent years including DNA methylation [ [148] , [149] , [150] , [151] , [152] , [153] , [154] , [155] , [156] , [157] , [158] , [159] , [160] , [161] ], messenger RNA (mRNA) [ [162] , [163] , [164] , [165] , [166] ], microRNA (miRNA) [ 167 ], protein mass spectrometry for seminal fluid detection [ 168 ], and microbiome analysis [ 169 , 170 ]. Although many new techniques are being described in the scientific literature, traditional methods for semen identification are still widely used in regular forensic casework [ 171 ].

When using RNA assays, DNA and RNA are co-extracted from examined samples [ 172 , 173 ]. Some tests may only distinguish between two possible body fluids, such as saliva and vaginal fluid [ 174 ], while other tests may attempt to distinguish six forensically relevant body fluids – vaginal fluid, seminal fluids, sperm cells, saliva, menstrual blood, and peripheral blood – although not always as clearly as desired [ 175 ]. BFID assays must also cope with mixed body fluids [ 176 ].

2.4. DNA collection and extraction

The process of obtaining a DNA profile begins with collecting a biological sample and extracting DNA from it. A review of recent trends and developments in forensic DNA extraction focused on isolating male DNA in sexual assault cases, using portable rapid DNA testing instruments, recovering DNA from difficult samples such as human remains, and bypassing DNA extraction altogether with direct PCR methods [ 177 ].

2.4.1. Touch evidence and fingerprint processing methods

Various studies have explored the compatibility of common fingerprint processing methods with DNA typing results [ [178] , [179] , [180] , [181] , [182] , [183] , [184] , [185] , [186] , [187] , [188] ]. For example, DNA recovery was explored after various steps in three different latent fingerprint processing methods – and fewer treatments were judged preferable with a 1,2-indanedione-zinc (IND/Zn) method appearing least harmful to downstream DNA analysis [ 187 ]. A different study found improved recovery of DNA from cigarette butts following latent fingerprint processing with 1,8-diazafluoren-9-one (DFO) compared to IND/Zn [ 179 ].

DNA losses were quantified with mock fingerprints deposited on four different surfaces to better understand DNA collection and extraction method performance [ 189 ]. The application of Diamond Dye has been shown to enable visualization of cells deposited on surfaces without interfering with subsequent PCR amplification and DNA typing [ [190] , [191] , [192] ].

It was possible to recover DNA profiles from clothing that someone touched for as little as 2 s [ 193 ]. DNA sampling success rates from car seats and steering wheels were studied [ 194 ] and recovery of DNA from vehicle surfaces using different swabs was explored [ 195 ]. In addition, the double-swab technique, where a wipe using a wet swab is followed by a wipe with a dry one, was revisited with an observation that for non-absorbing surfaces, the first web swab yielded 16 times more DNA than the second dry swab [ 196 ]. Swabs of cotton, flocked nylon, and foam reportedly provided equivalent DNA recoveries for smooth/non-absorbing surfaces, and an optimized swabbing technique involving the application of a 60-degree angle and rotating the swab during sampling improved DNA yields for cotton swabs [ 197 ].

2.4.2. Results from unfired and fired cartridge cases

Ammunition needs to be handled to load a weapon and thus DNA from the handler may be deposited onto the ammunition via touch [ 198 ]. Important progress has been made in recovering DNA from ammunition such as unfired cartridges or fired cartridge cases (FCCs) that may remain at a crime scene after a weapon has been fired. Trace quantities of DNA recovered from firearm or FCC surfaces has been used to try and link results to gun-related crimes.

A 2019 review of the literature regarding obtaining successful DNA results from ammunition examined collection techniques, extraction methodologies, and various amplification kits and conditions [ 199 ]. A direct PCR approach detected more STR alleles than methods using DNA extraction, and the authors noted that mixtures are commonly observed from gun surfaces, bullets, and cartridges in both controlled experimental conditions and from actual casework evidence and they encourage careful interpretation of these results [ 200 ]. The development of a crime scene FCC collector was combined with a new DNA recovery method that uses a rinse-and-swab technique [ 201 ].

Research studies and review articles have considered factors affecting DNA recovery from cartridge cases and the impact of metal surfaces on DNA recovery [ [202] , [203] , [204] , [205] , [206] , [207] , [208] , [209] ]. Recovery of mtDNA from unfired ammunition components has been assessed for sequence quality [ 210 ].

2.5. DNA typing

Following collection of DNA evidence and its extraction from biological samples, the typical typing process involves DNA quantitation, PCR amplification of STR markers, and STR typing using capillary electrophoresis. Direct PCR avoids the DNA extraction and quantitation steps, which can improve recovery of trace amounts of DNA [ 211 , 212 ]. Whole genome amplification prior to STR analysis has also been examined to aid recovery of degraded DNA [ 213 ] and to enable profiling of single sperm cells [ 214 ].

PCR amplification using STR typing kits can sometimes produce artifacts that impact DNA interpretation including missing (null) alleles [ 215 ], false tri-allelic patterns [ 216 ] or extra peaks when amplified in the presence of microbial DNA [ [217] , [218] , [219] ].

Applied Biosystems Genetic Analyzers have been the primary means of performing multi-colored capillary electrophoresis for many years [ 4 ]. First experiences with Promega's new Spectrum Compact CE System have recently been reported [ 220 ]. A number of new research and commercial STR kits have been introduced in recent years along with the publication of at least 24 validation studies ( Table 5 ). These validation studies typically follow guidelines outlined by the ENFSI DNA Working Group, 39 SWGDAM 40 , or a 2009 Chinese National Standard. 41

STR kits assessed with 24 published validation studies during 2019–2022.

A report on the first two years of submissions to the STRidER 42 (STRs for Identity ENFSI Reference) database for online allele frequencies revealed that 96% of the submitted 165 autosomal STR datasets generated by CE contained errors, showing the value of centralized quality control and data curation [ 245 ].

2.6. DNA interpretation at the source or sub-source level

The designation of STR alleles and genotypes of contributors in DNA mixtures are key aspects of DNA interpretation [ 246 , 247 ]. Electropherograms generated by CE instruments exhibit both STR alleles and artifacts that complicate data interpretation. Efforts are underway to understand and model instrumental artifacts [ [248] , [249] , [250] , [251] ] as well as biological artifacts of the PCR amplification process such as STR stutter products [ 252 , 253 ]. Machine learning approaches are being applied to classify artifacts versus alleles with the goal to eventually replace manual data interpretation with computer algorithms [ [254] , [255] , [256] , [257] ]. One such program, FaSTR DNA, enables potential artifact peaks from stutter, pull-up, and spikes to be filtered or flagged, and a developmental validation has been published examining 3403 profiles generated with seven different STR kits [ 258 ].

2.6.1. DNA mixture interpretation

Forensic evidence routinely contains contributions from multiple donors, which result in DNA mixtures. A number of approaches have been taken and advances made in DNA mixture interpretation [ 259 ]. These include probabilistic genotyping software [ 15 ], using genetic markers beyond traditional autosomal STR typing [ 260 ], or separating contributor cells and performing single-cell analysis [ [261] , [262] , [263] , [264] , [265] , [266] ].

In June 2021, the National Institute of Standards and Technology (NIST) released a draft report regarding the scientific foundations of DNA mixture interpretation [ 267 ]. This 250-page document described 16 principles that underpin DNA mixture interpretation, provided 25 key takeaways, and cited 528 references. NIST also began a Human Factors Expert Working Group on DNA Interpretation in February 2020 and plans to release a report with recommendations in 2023.

Assessment of the number of contributors (NoC) is a critical element of accurate DNA mixture interpretation. For example, the LRs relating to minor contributors can be reduced when the incorrect number of contributors is assumed [ 268 ]. Allele sharing among contributors to a mixture and masking of alleles due to STR stutter artifacts can lead to inaccurate NoC estimates based on simply counting the number of alleles at a locus. Different approaches and software programs have been used for NoC estimation [ [269] , [270] , [271] , [272] , [273] , [274] , [275] ]. Total allele count (TAC) distribution via TAC curves showed an improvement in manually estimating the number of contributors with complex mixtures [ 276 ]. Sequence analysis of STR loci expands the number of possible alleles compared to CE-based length measurements and thus can improve NoC estimates [ 277 ].

In the past three years, validation studies have been performed with a number of probabilistic genotyping software (PGS) systems including EuroForMix [ 278 ], DNAStatistX [ 279 , 280 ], TrueAllele [ 281 ], STRmix [ 282 ], Statistefix [ 283 ], Mixture Solution [ 284 ], Kongoh [ 285 ], and MaSTR [ 286 , 287 ]. Developers of EuroForMix, DNAStatistX, and STRmix provided a review of these systems [ 288 ]. Multi-laboratory assessments have been described [ 289 , 290 ] and likelihood ratios obtained from EuroForMix and STRmix compared [ [291] , [292] , [293] , [294] ]. With a growing literature in this area, there are many other articles that could have been cited.

2.7. DNA interpretation at the activity level

DNA interpretation at the source or sub-source level helps to answer the question of who deposited the cell material, whether attribution for the result can be made to a specific cell type (i.e., source level) or simply to the DNA if no attribution can be made to a specific cell type (i.e., sub-source level). Activity-level propositions seek to answer the question of how did an individual's cell material get there. Interpretation at the activity level is sometimes referred to as evaluative reporting [ 295 , 296 ].

In 2020, the ISFG DNA Commission [ 38 ] discussed the why, when, and how to carry out evaluative reporting given activity level propositions through providing examples of formulating these propositions. These Commission recommendations emphasize that reports using a likelihood ratio based on case-specific propositions and relevant conditioning information should highlight the assumptions being made and that “it is not valid to carry over a likelihood ratio from a low level, such as sub-source, to a higher level such as source or activity propositions … because the LRs given sub-source level propositions are often very high and LRs given activity level propositions will often be many orders of magnitude lower” [ 38 ]. Another recommendation specifies that “scientists must not give their opinion on what is the ‘most likely way of transfer’ (direct or indirect), as this would amount to giving an opinion on the activities and result in a prosecutor's fallacy (i.e., give the probability that X is true). The scientists' role is to assess the value of the results if each proposition is true in accordance with the likelihood ratio framework (the probability of the results if X is true and if Y is true)” [ 38 ] (emphasis in the original). This DNA Commission provided 11 recommendations and 4 considerations that should be studied carefully by those who implement activity-level DNA interpretation.

2.7.1. DNA transfer and persistence studies

To evaluate DNA findings given activity-level propositions it is important to understand the factors and variables that may impact DNA transfer, persistence, prevalence, and recovery (DNA-TPPR). These factors include history of contacting surfaces, biological material type, quantity and quality of DNA, dryness of biological material, manner and duration of contact, number and order of contacts, substrate type(s), time lapses and environment, and methods and thresholds used in the forensic DNA laboratory to generate the available data [ 297 ].

Three valuable review articles were published on this topic in 2019 [ 14 , 28 , 299 ]. Following a comprehensive January 2019 review that cited [ 298 ] references on DNA-TPPR [ 14 ], the same authors provided an update in November 2021 on recent progress towards meeting challenges and a synopsis of 144 relevant articles published between January 2018 and March 2021 [ 297 ]. While few studies provide the information needed to help assign probabilities of obtaining DNA results given specific sets of circumstances, progress includes use of Bayesian Networks [ 300 ] to identify variables for complex transfer scenarios [ 38 , [301] , [302] , [303] , [304] , [305] ] as well as development of an online database DNA-TrAC 43 for relevant research articles [ 299 ] and a structured knowledge base 44 with information to help practitioners interpret general transfer events at an activity level [ 306 ].

Forensic DNA pioneer Peter Gill emphasized that awareness of the limitations of DNA evidence is important for users of this data given that an increased sensitivity of modern DNA methods means that DNA may be recovered that is irrelevant to the crime under investigation [ 307 ]. An ISFG DNA Commission (see Section 1.2.5 ) emphasized that the strength of evidence associated with a DNA match at the sub-source level cannot be carried over to activity level propositions [ 38 ]. Structuring case details into propositions, assumptions, and undisputed case information has been encouraged [ 308 ].

Factors affecting variability of DNA recovery on firearms were studied with four realistic, casework-relevant handling scenarios along with results obtained including DNA quantities, number of contributors, and relative profile contributions for known and unknown contributors [ 309 ]. These studies found that sampling several smaller surfaces on a firearm and including the sampling location in the evaluation process can be helpful in assessing results given alternative activity-level propositions in gun-related crimes. The authors recommend that “further extensive, detailed and systematic DNA transfer studies are needed to acquire the knowledge required for reliable activity-level evaluations” [ 309 ].

Other recent studies on DNA-TPPR include examining prevalence and persistence of DNA or saliva from car drivers and passengers [ [310] , [311] , [312] ], evaluation of DNA from regularly-used knives after a brief use by someone else [ 313 ], studying the accumulation of endogenous and exogenous DNA on hands [ 314 ] and non-self-DNA on the neck [ 315 ], considering the potential of DNA transfer via work gloves [ 316 , 317 ] or during lock picking [ 318 ], and investigating whether DNA can be recovered from illicit drug capsules [ 319 , 320 ] or packaging [ 321 ] to identify those individuals preparing or handling the drugs.

Efforts have been made to estimate the quantity of DNA transferred in primary versus secondary transfer scenarios [ 322 ]. As quantities of DNA transferred can be highly variable and thought to be dependent on the so-called “shedder status” – how much DNA an individual exudes, several studies explored this topic [ [323] , [324] , [325] , [326] , [327] ]. Studies have also considered the level of DNA an individual transfers to untouched items in their immediate surroundings [ 328 ], the position and level of DNA transferred during digital sexual assault [ 329 ] or during various activities with worn upper garments [ 330 , 331 ], and the DNA composition on the surface of evidence bags pre- and post-exhibit examination [ 332 ]. Studies assessing background levels of male DNA on underpants worn by females [ 333 ] and background levels of DNA on flooring within houses [ 334 ] are providing important knowledge about the possibilities and probabilities of DNA transfer and persistence.

The authors of one study summarize some key points that could be extended to many other studies as words of caution: “From a wider trace DNA point of view, this study has demonstrated that the person who most recently handled an item may not be the major contributor and someone who handled an item for longer may still not be the major contributor if they remove more DNA than they deposit. The amount of DNA transferred and retained on an item is highly variable between individuals and even within the same individual between replicates” [ 320 ].

3. Emerging technologies, research studies, and other topics

New technologies to aid forensic DNA typing are constantly under development. This section explores recent activities with next-generation DNA sequencing, DNA phenotyping for estimating a sample donor's age, ancestry, and appearance, lineage markers, other markers and approaches, and non-human DNA and wildlife forensics, and is expected to be of value to researchers and those practitioners looking to future directions in the field.

3.1. Next-generation sequencing

Next-generation sequencing (NGS), also known as massively parallel sequencing (MPS) in the forensic DNA community, expands the measurement capabilities and information content of a DNA sample beyond the traditional length-based results with STR markers obtained with capillary electrophoresis (CE) methods. Additional genetic markers, such as single nucleotide polymorphisms (SNPs), microhaplotypes, and mitochondrial genome (mtGenome) sequence, may be analyzed along with the full sequence of STR alleles. This higher information content per sample opens up new potential applications such as phenotyping of externally visible characteristics and biogeographical ancestry as described in review articles [ 335 , 336 ].

As mentioned in Section 1.2.1 , the NIJ Forensic Laboratory Needs Technology Working Group (FLN-TWG) published a 29-page implementation strategy on next-generation sequencing for DNA analysis in September 2021 [ 28 ]. This guide discusses how NGS works and its advantages and disadvantages, the various instrument platforms and commercial kits available with approximate costs, items to consider regarding facilities, data storage, and personnel training, and resources for implementing NGS technology. A total of 73% of 105 forensic DNA laboratories surveyed from 32 European countries already own an MPS platform or plan to acquire one in the next year or two and one-third of the survey participants already conduct MPS-based STR sequencing, identity, or ancestry SNP typing [ 337 ].

Validation studies have been described with the ForenSeq DNA Signature Prep kit and the MiSeq FGx system [ [338] , [339] , [340] ], with the Verogen ForenSeq Primer Mix B for phenotyping and biogeographical ancestry predictions [ 341 , 342 ], and for resizing reaction volumes with the ForenSeq DNA Signature Prep kit library preparation [ 343 ]. MPS sequence data showed excellent allele concordance with CE results for 31 autosomal STRs in the Precision ID GlobalFiler NGS STR Panel from 496 Spanish individuals [ 344 ] and from 22 autosomal STR loci in the PowerSeq 46GY panel with 247 Austrians [ 345 ].

STR flanking region sequence variation has been explored [ 346 ] and reports of population data and sequence variation were published for samples from India [ 347 ], France [ 348 ], China [ 349 , 350 ], Korea [ 351 ], Brazil [ 352 ], Tibet [ 353 ], and the United States [ 354 ].

In April 2019 the STRAND ( S hort T andem R epeat: A lign, N ame, D efine) Working Group was formalized [ 355 ] to consider several possible approaches to sequence-based STR nomenclature that have been proposed [ 356 , 357 ]. An overview of software options has been provided for analysis of forensic sequencing data [ 358 ]. Some recent published options include STRinNGS [ 359 ], STRait Razor [ 360 ], ArmedXpert tools MixtureAce and Mixture Interpretation to analyze MPS-STR data [ 361 ], and STRsearch for targeted profiling of STRs in MPS data [ 362 ]. To aid interpretation of MPS-STR data, sensitivity studies were performed with single-source samples and sequence data analyzed by DNA quantity and method used [ 363 ]. A procedure has been described to address calculation of match probabilities when results are generated using MPS kits with different trim sites than those present in the relevant population frequency database [ 364 ]. Performance of different MPS kits, markers, or methods can be compared for accuracy and precision using the Levenshtein distance metric [ 365 ].

Novel MPS STR and SNP panels developed in recent years include IdPrism [ 366 ], a QIAGEN 140-locus SNP panel [ 367 ], the 21plex monSTR identity panel [ 368 ], a 42plex STR NGS panel to assist with kinship analysis [ 369 ], the 5422 marker FORCE (FORensic Capture Enrichment) panel [ 370 ], a forensic panel with 186 SNPs and 123 STRs [ 371 ], the SifaMPS panel for targeting 87 STRs and 294 SNPs [ 372 ], a 1245 SNP panel [ 373 ], 90 STRs and 100 SNPs for application with kinship cases [ 374 ], an adaption of the SNPforID 52plex panel to MPS [ 375 ], 448plex SNP panel [ 376 ], a 133plex panel with 52 autosomal and 81 Y-chromosome STRs [ 377 ], and a forensic identification multiplex with 1270 tri-allelic SNPs involving 1241 autosomal and 29 X-chromosome markers [ 378 ]. The 124 SNPs in the Precision ID Identity Panel were examined in a central Indian population [ 379 ] and human leukocyte antigen (HLA) alleles used in the early 1990s were revisited with MPS capability [ [380] , [381] , [382] ].

MPS methods have demonstrated utility with compromised samples [ [383] , [384] , [385] , [386] , [387] , [388] ] and mixture interpretation [ [389] , [390] , [391] , [392] , [393] , [394] , [395] ]. Microhaplotype assays have also been developed to assist with DNA mixture deconvolution [ 396 , 397 ]. Collaborative studies have explored variability with laboratory performance using MPS methods [ 398 , 399 ]. Population structure [ 400 ] and linkage and linkage disequilibrium [ 401 ] were examined among the markers in forensic MPS panels.

A review of transcriptome analysis using MPS discussed efforts with body fluid and tissue identification, determination of the time since deposition of stains and the age of donors, the estimation of post-mortem interval, and assistance to post-mortem death investigations [ 402 ]. The potential for MPS methods to assist with environmental trace analysis was reviewed in terms of forensic soil analysis, forensic botany, and human identification utilizing the skin microbiome [ 403 ]. The possibility of non-invasive prenatal paternity testing using cell-free fetal DNA from maternal plasma was explored with the Precision ID Identity Panel [ 404 ] and the ForenSeq DNA Signature Prep Kit [ 405 ]. Pairwise kinship analysis was also examined using the ForenSeq DNA Signature Prep Kit and multi-generational family pedigrees [ 406 , 407 ]. Nanopore sequencing has also been explored for sequencing STR and SNP markers [ [408] , [409] , [410] , [411] , [412] , [413] , [414] , [415] , [416] ].

3.2. DNA phenotyping (ancestry, appearance, age)

Continuing research into the genetic components of biogeographic ancestry, appearance, and age predictions have improved forensic DNA phenotyping capabilities [ 417 ]. These forensic innovations may sometimes impact public expectations [ 418 ]. The investigation in a murder case was assisted using information from forensic DNA phenotyping that predicted eye, hair, and skin color of an unknown suspect with the HIrisPlex-S system involving targeted massively parallel sequencing [ 419 ].

The VISAGE ( Vis ible A ttributes Through Ge nomics) Consortium, which consists of 13 partners from academic, police, and justice institutions in 8 European countries, has established new scientific knowledge and developed and tested prototype tools for DNA analysis and statistical interpretation as well as conducted education for stakeholders. In the 2019 to 2022 time window of this review, this concerted effort produced 45 one review article [ 417 ], 22 original research publications [ 337 , [420] , [421] , [422] , [423] , [424] , [425] , [426] , [427] , [428] , [429] , [430] , [431] , [432] , [433] , [434] , [435] , [436] , [437] , [438] , [439] , [440] ], and three reports [ [441] , [442] , [443] ].

DNA phenotyping is currently an active area of research, and numerous activities and publications exist beyond the VISAGE articles noted here. Another 137 articles have appeared in the literature in the past three years on biogeographical ancestry, appearance (primarily hair color, eye color, and skin color), and biological age predictions (typically utilizing DNA methylation) (see Supplemental File ).

3.3. Lineage markers (Y-chromosome, mtDNA, X-chromosome)

Lineage markers consist of Y-chromosome, mitochondrial DNA, and X-chromosome genetic information that may be inherited from just one parent without the regular recombination that occurs with autosomal DNA markers. Research in terms of new markers, assays, and population studies continue to be published for these lineage markers.

3.3.1. Y-chromosome

Several recent review articles were published on forensic applications of Y-chromosome testing [ [444] , [445] , [446] ]. As discussed previously in Section 1.2 , an ISFG DNA Commission summarized the state of the field with Y-STR interpretation [ 39 ]. Rapidly mutating Y-STR loci can be used to differentiate closely related males [ [447] , [448] , [449] ]. New statistical approaches to assessing evidence with Y-chromosome information have been described [ 450 , 451 ]. Four commercial Y-STR multiplexes were compared with the NIST 1032 U S. population sample set and the allele and haplotype diversities explored with length-based versus sequence-based information [ 452 ].

A number of Y-STR typing systems have been described along with validation studies, such as a 36plex [ 453 ], a 41plex [ 454 ], a 29plex [ 455 ], a 17plex [ 456 ], a 24plex [ 457 ], the Microreader 40Y ID System [ 458 ], the 24 Y-STRs in the AGCU Y SUPP STR kit [ 459 ], the DNATyper Y26 PCR amplification kit [ 460 ], a multiplex with 12 multicopy Y-STR loci [ 461 ], the Yfiler Platinum PCR Amplification Kit [ 462 ], a 45plex [ 463 ], the Microreader 29Y Prime ID system [ 464 ], an assay with 30 slow and moderate mutation Y-STR markers [ 465 ], the 17plex Microreader RM-Y ID System [ 466 ], and a 26plex for rapidly mutating Y-STRs [ 467 ]. A machine learning program predicted Y haplogroups using two Y-STR multiplexes with 32 Y-STRs [ 468 ].

Deletions and duplications with 42 Y-STR were reported in a sample of 1420 unrelated males and 1160 father-son pairs from a Chinese Han population [ 469 ]. Using Y-STR allele sequences has enabled locating parallel mutations in deep-rooting family pedigrees [ 470 ]. The surname match frequency with Y-chromosome haplotypes was explored using 2401 males genotyped for 46 Y-STRs and 183 Y-SNPs [ 471 ]. In the Y-chromosome's role as a valuable kinship indicator to assist in genetic genealogy and forensic research, models to improve prediction of the time to the most recent common paternal ancestor have been studied with 46 Y-STRs and 1120 biologically related genealogical pairs [ 472 ]. A massively parallel sequencing tool was developed to analyze 859 Y-SNPs to infer 640 Y haplogroups [ 473 ]. Another MPS tool, the CSYseq panel, targeted 15,611 Y-SNPs to categorize 1443 Y-sub-haplogroup lineages worldwide along with 202 Y-STRs including 81 slow, 68 moderate, 27 fast, and 26 rapidly mutating Y-STRs to individualize close paternal relatives [ 474 ].

3.3.2. Mitochondrial DNA

Mitochondrial DNA (mtDNA), which is maternally inherited with a high copy number per cell, can aid human identification, missing persons investigations, and challenging forensic specimens containing low quantities of nuclear DNA such as hair shafts [ [475] , [476] , [477] ]. Validation studies have been published using traditional Sanger sequencing [ 478 ] and next-generation sequencing [ [479] , [480] , [481] ]. Illumina and Thermo Fisher now provide mtDNA whole genome NGS assays [ [482] , [483] , [484] , [485] ]. Many mtDNA population data sets were published in the past three years including high-quality data from U.S. populations [ 486 ]. The suitability of current mtDNA interpretation guidelines for whole mtDNA genome (mtGenome) comparisons has been evaluated [ 487 ].

NGS methods have increased sensitivity of mtDNA heteroplasmy detection [ 488 , 489 ], which can influence the ability to connect buccal reference samples and rootless hairs from the same individual [ 490 , 491 ]. Twelve polymerases were compared in terms of mtDNA amplification yields from challenging hairs – with KAPA HiFi HotStart and PrimeSTR HS outperforming AmpliTaq Gold DNA polymerase that is widely used in forensic laboratories [ 492 ]. Multiple studies and review articles have discussed distinguishing mtDNA from nuclear DNA elements of mtDNA (NUMTs) that have been inserted into our nuclear DNA [ [493] , [494] , [495] , [496] ].

NGS sequencing of the mtGenome has permitted improved resolution of the most common West Eurasian mtDNA control region haplotype [ 497 ]. Phylogenetic alignment and haplogroup classification have continued to be refined with new sequence information [ 498 ], and new assays have been developed to aid haplogroup classification [ 499 ]. Concerns over potential paternal inheritance of mtDNA have also been addressed [ 500 , 501 ].

3.3.3. X-chromosome

A 20-year review of X-chromosome use in forensic genetics examined the number and types of markers available, an overview of worldwide population data, the use of X-chromosome markers in complex kinship testing, mutation studies, current weaknesses, and future prospects [ 502 ]. One example of the forensic application of X-chromosome markers include use in relationship testing cases involving suspicion of incest or paternity without a maternal sample for comparison [ 503 ]. Four new X-STR multiplex assays were described along with validation studies including a 19plex [ 504 ], a 16plex [ 505 ], another 19plex – the Microreader 19X Direct ID System [ 506 ], and an 18plex named TYPER-X19 multiplex assay [ 507 ]. A collaborative study examined paternal and maternal mutations in X-STR markers [ 508 ]. A software program for performing population statistics on X-STR data was introduced [ 509 ] and sequence-based U.S. population data described for 7 X-STR loci [ 510 ].

3.4. New markers and approaches (microhaplotypes, InDels, proteomics, human microbiome)

In this section on new markers and approaches, publications related to microhaplotypes and insertion/deletion (InDel, or DIP for deletion insertion polymorphisms) markers are reviewed along with proteomic and microbiome approaches to supplement standard human DNA typing methods.

3.4.1. Microhaplotypes

Microhaplotype (MH) markers consist of multiple SNPs in close proximity (e.g., typically <200 bp or <300 bp) that can be simultaneously genotyped with each DNA sequence read using NGS. Two or more linked SNPs will define three or more haplotypes. Compared to STR markers, MHs do not have stutter artifacts (which complicate mixture interpretation), can be designed with shorter amplicon lengths in some cases (which benefits recovery of genetic information from degraded DNA samples), possess a higher degree of polymorphism compared to single SNP loci (which benefits discrimination power), and exhibit low mutation rates (which enables relationship testing and biogeographical ancestry inference). Thus, MH markers bring advantages to human identification, ancestry inference, kinship analysis, and mixture deconvolution to potentially assist missing person investigations, relationship testing, and forensic casework as discussed in several recent reviews [ 16 , 511 ]. A new database, MicroHapDB, has compiled information on over 400 published MH markers and frequency data from 26 global population groups [ 512 ].

A number of MH panels have been described [ [513] , [514] , [515] , [516] , [517] , [518] , [519] ]. Population data has been collected from a number of sources around the world including four U.S. population groups examined with a 74plex assay with 74 MH loci and 230 SNPs [ 520 ]. Various MH panels have been evaluated for effectiveness with kinship analysis [ [521] , [522] , [523] ]. Likewise the ability to detect minor contributors in DNA mixtures has been assessed [ [524] , [525] , [526] ].

3.4.2. InDel markers

InDel markers can be detected using a CE-based length analysis, and thus use instrumentation that forensic DNA laboratories already have. InDels can also be designed to amplify short DNA fragments (e.g., <125 bp) to help improve amplification success rates with low DNA quantity and/or quality. However, with only two possible alleles like SNPs, InDels are not as polymorphic as STRs and thus require more markers to obtain similar powers of discrimination as multi-allelic STR markers and do not work as well with mixed DNA samples. InDels possess a lower mutation rate than STRs and can be used as ancestry informative markers (AIMs) since allele frequencies may differ among geographically separated population groups.

Two commercial InDel kit exist: (1) Investigator DIPlex (QIAGEN, Hilden, Germany) with 30 InDels [ [527] , [528] , [529] , [530] , [531] ] and (2) InnoTyper 21 (InnoGenomics, New Orleans, Louisiana, USA) with 21 autosomal insertion-null (INNUL) markers [ [532] , [533] , [534] , [535] ]. In addition, a number of InDel assays have been published including a 32plex [ 536 ], a 35plex [ 537 ], a 38plex [ 538 ], a 39plex with AIMs [ 539 ], a 43plex [ 540 ], a 57plex [ 541 ], a 60plex with 57 autosomal InDels, 2 Y-chromosome InDels, and amelogenin [ 542 ], a 32plex with X-chromosome InDels [ 543 ], and a 21plex with AIMs [ 544 ].

A multi-InDel marker is a specific DNA fragment with more than one InDel marker located tightly in the physical position that provides a microhaplotype [ 545 ]. Several multi-InDel assays have been published include a 12plex [ 546 ] and an 18plex [ 547 ].

3.4.3. Proteomics

Protein analysis, often through immunological assays, has traditionally been used to identify body fluids and tissues. With improvements in protein mass spectrometry in recent years, genetic variation can be observed in hair shafts via single amino acid polymorphisms. Detection of these genetically variant peptides (GVPs) can infer the presence of corresponding SNP alleles in the genome of the individual who is the source of the protein sample. A thorough review of forensic proteomics in 2021 cited 375 references [ 18 ]. Recent efforts in this area have focused on using GVPs to differentiate individuals through their human skin cells [ [548] , [549] , [550] ] or hair samples [ [551] , [552] , [553] , [554] , [555] , [556] , [557] , [558] , [559] ]. An algorithm has been proposed for calculating random match probabilities with GVP information [ 560 ].

3.4.4. Human microbiome

Microorganisms live in and on the human body, and efforts are underway to utilize the human microbiome for a variety of potential forensic applications [ 21 , [561] , [562] , [563] ]. There are also active efforts with analysis of microbiomes in the environment (e.g., soil or water samples), which could be classified under non-human DNA testing. Forensic microbiome research covers at least six areas: (1) individual identification, (2) tissue/body fluid identification, (3) geolocation, (4) time since stain deposition estimation, (5) forensic medicine, and (6) post-mortem interval (PMI) estimation. Biological, technical, and data issues have been raised and potential solutions explored in a recent review article [ 21 ]. For example, microbes on deceased individuals are being studied to estimate the postmortem interval [ 20 ] and postmortem skin microbiomes were found to be stable during repeated sampling up to 60 h postmortem [ 564 ].

Sequence analysis of 16S rRNA using NGS provides information on the microbiome community present in a tested sample [ 565 ]. The Forensic Microbiome Database 46 correlates publicly available 16S rRNA sequence data as a community resource. If the skin microbiome is extremely diverse among individuals, then the potential exists to associate the bacterial communities on an individual's skin with objects touched by this individual assuming that the bacteria originating from the donor's skin are deposited (i.e., transfer to and persist on the surface) and can be detected and interpreted.

Specific aspects of the microbiome (e.g., the bacterial community) may be able to provide details about the donor through bacterial profiling. For example, in one study correlations were observed between the bacterial profile and gender, ethnicity, diet type, and hand sanitizer used [ 566 ]. Another study with 30 individuals found that each person left behind microbial signatures that could be used to track interaction with various surfaces within a building, but the authors concluded “we believe the human microbiome, while having some potential value as a trace evidence marker for forensic analysis, is currently under-developed and unable to provide the level of security, specificity and accuracy required for a forensic tool” [ 565 ].

Direct and indirect transfer of microbiomes between individuals has been studied [ 567 , 568 ] along with identifying background microbiomes [ 569 ] and the possibility of transfer of microbiomes within a forensic laboratory setting [ 570 ]. Changes in four bacterial species in saliva stains were charted, showing that it was possible to correctly predict deposition time within one week in 80% of the stains [ 571 ]. The ability to detect sexual contact has been explored through using the microbiome of the pubic region [ [572] , [573] , [574] ]. The microbiomes on skin, saliva, vaginal fluid, and stool samples have been compared [ 575 ]. The stability, diversity, and individualization of the human skin virome was explored with 59 viral biomarkers being found that differed across the 42 individuals studied [ 576 ]. It will be interesting to see what the future holds and what other findings come from this active area of research.

3.5. Kinship analysis, human identification, and disaster victim identification

Kinship analysis, which uses genetic markers and statistics to evaluate the potential for specific biological relationships, is important for parentage testing, disaster victim identification (DVI), and human identification of remains that may be recovered in missing person cases. New open-source software programs have been described that can assist with kinship analysis [ 577 , 578 ].

A potential biological relationship is commonly evaluated using a likelihood ratio (LR) by comparing the likelihoods of observing the genetic data given two alternative hypotheses, such as (1) an individual is related to another individual in a defined relationship versus (2) the two individuals not related. Higher LR values indicate stronger support with the genetic data if the proposed relationship is true. Multiple factors influence LR kinship calculations including the specific hypotheses, the genetic markers examined, the allele frequencies of the relevant population(s), the co-ancestry coefficient applied, and approaches to address potential mutations. STR genotypes were reported for 11 population groups used by the FBI Laboratory [ 579 ]. The status quo has been challenged in recent articles regarding how hypotheses are commonly established [ 580 ] and whether race-specific U.S. population databases should be used for allele frequency calculations [ 581 ].

Depending on the relationship being explored, information can be optimized through genetic information from additional known relatives or through collecting results at more loci [ 582 ]. Potential error rates have been modeled with the observation that false negatives, which occur when related individuals are misinterpreted as being unrelated, are more common than false positives, where unrelated people are interpreted as being related [ 583 ]. While LRs are generally reliable in detecting or confirming parent/child pairs, limitations of kinship determinations exist (e.g., distinguishing siblings from half-siblings) when using STR data [ 584 ].

Pairwise comparisons have been studied in forensic kinship analysis [ [585] , [586] , [587] ]. The effectiveness of 40 STRs plus 91 SNPs was shown to be better than 27 STRs and 91 SNPs or 40 STRs alone [ 588 ]. Only a minor increase in LRs was observed when taking NGS-generated allele sequence variation rather than fragment length allele variation [ 589 ]. The statistical power of exclusion and inclusion can be used to prioritize family members selected for testing in resolving missing person cases [ 590 ]. A strategy for making decisions when facing low statistical power in missing person and DVI cases was published [ 591 ].

The most challenging kinship cases involve efforts to separate pairs of individuals who are typically thought to be genetically indistinguishable (i.e., monozygotic twins) or distant relatives (e.g., fourth cousins) where there is an increased uncertainty in the possible relationship. In some situations, somatic mutations may permit distinguishing monozygotic twins following whole genome sequencing – and this approach was successful in four of six cases reported recently [ 19 ]. The probative value of NGS data for distinguishing monozygotic twins was explored [ 592 ]. A unique case of heteropaternal twinning was reported where opposite-sex twins apparently had different fathers [ 593 ]. An impressive effort in kinship analysis using direct-to-consumer genetic genealogy information from 56 living descendants of multiple genealogical lineages helped resolve a contested paternity case from over a century and a half ago to identify the biological father of Josephine Lyon [ 594 ].

Techniques for identification of human remains continue to improve particularly with the capabilities of NGS and hybridization capture [ 595 ] and ancient DNA extraction protocols [ 596 , 597 ]. Studies have reported variation in skeletal DNA preservation [ 598 ] and retrospectively considered success rates with compromised human remains [ 599 ].

A simulated airplane crash enabled six forensic laboratories in Switzerland to gain valuable DVI experience with kinship cases of varying complexity [ 600 ]. The ISFG Spanish-Portuguese Speaking Working Group likewise conducted a DVI collaborative exercise with a simulated airplane crash to explore fragment re-associations, victim identification through kinship analysis, coping with related victims, handling mutations or insufficient number of family references, working in a Bayesian framework, and the correct use of DVI software [ 601 ]. Other groups have explored the capability of a particular software tool [ 602 ] or implemented rapid DNA analysis to accelerate victim identification [ 603 ]. The International Commission on Missing Persons (ICMP) has gained considerable experience with DNA extraction and STR amplification from degraded skeletal remains and kinship matching procedures in large databases [ 604 ]. To supplement the INTERPOL DVI Guide, 47 some lessons learned and experienced-based recommendations for DVI operations have recently been provided [ 605 ].

3.6. Non-human DNA testing and wildlife forensics

Non-human biological evidence may inform criminal investigations when animals or plants are victims or perpetrators of crime or the presence of specific material, such as cat or dog hair, may contribute to reconstructing events at a crime scene. Non-human DNA testing includes wildlife forensics and domestic animal species as well as forensic botany and has many commonalities and some important differences compared to human DNA testing [ [606] , [607] , [608] , [609] , [610] ]. Pollen analysis can assist criminal investigations [ 611 , 612 ]. The potential for and the barriers associated with the wider application of forensic botany in civil proceedings and criminal cases have been examined [ 613 , 614 ].

Mammalian species identification can assist in determining the origins of non-human biological material found at crime scenes through narrowing the range of possibilities [ 615 ]. New sequencing methods have been developed to assist species identification [ 616 ]. A multiplex PCR assay was developed to simultaneously identify 22 mammalian species (alpaca, Asiatic black bear, Bactrian camel, brown rat, cat, cow, common raccoon, dog, European rabbit, goat, horse, house mouse, human, Japanese badger, Japanese wild boar, masked palm civet, pig, raccoon dog, red fox, sheep, Siberian weasel, and sika deer) and four poultry species (chicken, domestic turkey, Japanese quail, and mallard) [ 617 ]. A number of other species identification assays have also been reported [ [618] , [619] , [620] ].

An important effort for harmonizing canine DNA analysis is an ISFG working group known as the Canine DNA Profiling Group, or CaDNAP. 48 The CaDNAP group published an analysis of 13 STR markers in 1184 dogs from Germany, Austria, and Switzerland [ 621 ]. Six traits for predicting visible characteristics in dogs, namely coat color, coat pattern, coat structure, body size, ear shape, and tail length, were explored with 15 SNPs and six InDel markers [ 622 ]. Canine breed classification and skeletal phenotype prediction has been explored using various genetic markers [ 623 ]. A novel assay using a feline leukemia virus was developed to demonstrate that a contested bobcat was not a domestic cat hybrid [ 624 ] and a core panel of 101 SNP markers was selected for domestic cat parentage verification and identification [ 625 ].

DNA tests have been developed to assist with illegal trafficking investigations involving elephant ivory seizures [ 626 ], falcons [ 627 ], and precious coral material [ 628 ]. Accuracy in animal forensic genetic testing was explored with interlaboratory assessments performed in 2016 and 2018 [ 629 ]. A collaborative exercise conducted in 2020 and 2021 by the ISFG Italian Speaking Working Group examined performance across 21 laboratories with a 13-locus STR marker test for Cannabis sativa [ 630 ]. A molecular approach was explored to distinguish drug-type versus fiber-type hemp varieties [ 631 ].

Acknowledgments and disclaimer

I am grateful to Dominique Saint-Dizier from the French National Scientific Police for the invitation and opportunity to conduct this review and for the support of my supervisor, Shyam Sunder, for granting the time to work on this extensive review. Input and suggestions on this manuscript by Todd Bille, Thomas Callaghan, Kevin Kiesler, François-Xavier Laurent, Robert Ramotowski, Kathy Sharpless, and Robert Thompson are greatly appreciated. Certain commercial entities, equipment, or materials may be identified in this document in order to describe an experimental procedure or concept adequately. Such identification is not intended to imply recommendation or endorsement by the National Institute of Standards and Technology, nor is it intended to imply that the entities, materials, or equipment are necessarily the best available for the purpose.

1 https://www.sciencedirect.com/journal/forensic-science-international-genetics/special-issue/10TSDS4360H .

2 https://www.mdpi.com/journal/genes/special_issues/Forensic_Genetic .

3 https://www.mdpi.com/journal/genes/special_issues/forensic_mitochondrial_genomics .

4 https://www.mdpi.com/journal/genes/special_issues/Advances_Forensic_Genetics .

5 https://www.mdpi.com/books/pdfdownload/book/5798 .

6 https://www.mdpi.com/journal/genes/special_issues/Bioinformatics_Forensic_Genetics .

7 https://www.mdpi.com/journal/genes/special_issues/genetics_anthropology .

8 https://www.mdpi.com/journal/genes/special_issues/Identification_of_Human_Remains .

9 https://www.mdpi.com/journal/genes/special_issues/Forensic_DNA_analysis .

10 https://www.mdpi.com/journal/genes/special_issues/Forensic_DNA_Mixture .

11 https://www.mdpi.com/journal/genes/special_issues/28FBA0G4DH .

12 See https://www.swgdam.org/ .

13 https://www.swgdam.org/publications .

14 https://www.fbi.gov/file-repository/rapid-dna-guide-january-2022.pdf/view .

15 https://www.fbi.gov/file-repository/non-codis-rapid-dna-best-practices-092419.pdf/view .

16 https://www.fbi.gov/file-repository/rapid-dna-testing-for-non-codis-uses-considerations-for-court-073120.pdf/view .

17 https://www.justice.gov/olp/uniform-language-testimony-and-reports .

18 https://forensiccoe.org/human_factors_forensic_science_sourcebook/ .

19 https://www.nist.gov/organization-scientific-area-committees-forensic-science .

20 https://www.nist.gov/organization-scientific-area-committees-forensic-science/human-forensic-biology-subcommittee .

21 https://www.nist.gov/topics/organization-scientific-area-committees-forensic-science/wildlife-forensics-subcommittee .

22 https://www.aafs.org/academy-standards-board .

23 https://www.nist.gov/organization-scientific-area-committees-forensic-science/osac-registry .

24 See https://www.nist.gov/organization-scientific-area-committees-forensic-science/human-forensic-biology-subcommittee .

25 https://lexicon.forensicosac.org/ .

26 https://www.nist.gov/osac/human-factors-validation-and-performance-testing-forensic-science .

27 https://www.nist.gov/organization-scientific-area-committees-forensic-science/osac-research-and-development-needs .

28 https://www.gov.uk/government/publications/forensic-science-providers-codes-of-practice-and-conduct-2021-issue-7 .

29 https://www.aabb.org/standards-accreditation/standards/relationship-testing-laboratories .

30 https://www.isfg.org/DNA+Commission .

31 Previously available rapid DNA systems included the RapidHIT 200 from IntegenX and MiDAS (Miniaturized integrated DNA Analysis System) from the Center for Applied NanoBioscience at the University of Arizona.

32 See https://le.fbi.gov/science-and-lab-resources/biometrics-and-fingerprints/codis/rapid-dna .

33 See https://www.interpol.int/How-we-work/Forensics/DNA .

34 See https://www.interpol.int/How-we-work/Forensics/I-Familia .

35 See https://le.fbi.gov/science-and-lab-resources/biometrics-and-fingerprints/codis#Familial-Searching .

36 See https://isogg.org/wiki/Autosomal_DNA_testing_comparison_chart .

37 See https://www.wmar2news.com/infocus/maryland-quietly-shelves-parts-of-genealogy-privacy-law .

38 See https://www.hhs.gov/ohrp/regulations-and-policy/regulations/finalized-revisions-common-rule/index.html .

39 See https://enfsi.eu/about-enfsi/structure/working-groups/dna/ .

40 See https://www.swgdam.org/publications .

41 See https://www.chinesestandard.net/PDF/English.aspx/GAT815-2009 .

42 See https://strider.online/ .

43 See https://bit.ly/2R4bFgL (DNA-TrAC).

44 See https://cieqfmweb.uqtr.ca/fmi/webd/OD_CIEQ_CRIMINALISTIQUE (Transfer Traces Activity DataBase).

45 See https://www.visage-h2020.eu/index.html#publications .

46 See http://fmd.jcvi.org/ .

47 See https://www.interpol.int/en/How-we-work/Forensics/Disaster-Victim-Identification-DVI .

48 See https://www.isfg.org/Working+Groups/CaDNAP .

Appendix A Supplementary data to this article can be found online at https://doi.org/10.1016/j.fsisyn.2022.100311 .

Appendix A. Supplementary data

The following is the supplementary data to this article:

200+ Biotechnology Research Topics: Let’s Shape the Future

In the dynamic landscape of scientific exploration, biotechnology stands at the forefront, revolutionizing the way we approach healthcare, agriculture, and environmental sustainability. This interdisciplinary field encompasses a vast array of research topics that hold the potential to reshape our world. 

In this blog post, we will delve into the realm of biotechnology research topics, understanding their significance and exploring the diverse avenues that researchers are actively investigating.

Overview of Biotechnology Research

Table of Contents

Biotechnology, at its core, involves the application of biological systems, organisms, or derivatives to develop technologies and products for the benefit of humanity. 

The scope of biotechnology research is broad, covering areas such as genetic engineering, biomedical engineering, environmental biotechnology, and industrial biotechnology. Its interdisciplinary nature makes it a melting pot of ideas and innovations, pushing the boundaries of what is possible.

How to Select The Best Biotechnology Research Topics?

• Identify Your Interests

Start by reflecting on your own interests within the broad field of biotechnology. What aspects of biotechnology excite you the most? Identifying your passion will make the research process more engaging.

• Stay Informed About Current Trends

Keep up with the latest developments and trends in biotechnology. Subscribe to scientific journals, attend conferences, and follow reputable websites to stay informed about cutting-edge research. This will help you identify gaps in knowledge or areas where advancements are needed.

• Consider Societal Impact

Evaluate the potential societal impact of your chosen research topic. How does it contribute to solving real-world problems? Biotechnology has applications in healthcare, agriculture, environmental conservation, and more. Choose a topic that aligns with the broader goal of improving quality of life or addressing global challenges.

• Assess Feasibility and Resources

Evaluate the feasibility of your research topic. Consider the availability of resources, including laboratory equipment, funding, and expertise. A well-defined and achievable research plan will increase the likelihood of successful outcomes.

• Explore Innovation Opportunities

Look for opportunities to contribute to innovation within the field. Consider topics that push the boundaries of current knowledge, introduce novel methodologies, or explore interdisciplinary approaches. Innovation often leads to groundbreaking discoveries.

• Consult with Mentors and Peers

Seek guidance from mentors, professors, or colleagues who have expertise in biotechnology. Discuss your research interests with them and gather insights. They can provide valuable advice on the feasibility and significance of your chosen topic.

• Balance Specificity and Breadth

Strike a balance between biotechnology research topics that are specific enough to address a particular aspect of biotechnology and broad enough to allow for meaningful research. A topic that is too narrow may limit your research scope, while one that is too broad may lack focus.

• Consider Ethical Implications

Be mindful of the ethical implications of your research. Biotechnology, especially areas like genetic engineering, can raise ethical concerns. Ensure that your chosen topic aligns with ethical standards and consider how your research may impact society.

• Evaluate Industry Relevance

Consider the relevance of your research topic to the biotechnology industry. Industry-relevant research has the potential for practical applications and may attract funding and collaboration opportunities.

• Stay Flexible and Open-Minded

Be open to refining or adjusting your research topic as you delve deeper into the literature and gather more information. Flexibility is key to adapting to new insights and developments in the field.

200+ Biotechnology Research Topics: Category-Wise

Genetic engineering.

• CRISPR-Cas9: Recent Advances and Applications
• Gene Editing for Therapeutic Purposes: Opportunities and Challenges
• Precision Medicine and Personalized Genomic Therapies
• Genome Sequencing Technologies: Current State and Future Prospects
• Synthetic Biology: Engineering New Life Forms
• Genetic Modification of Crops for Improved Yield and Resistance
• Ethical Considerations in Human Genetic Engineering
• Gene Therapy for Neurological Disorders
• Epigenetics: Understanding the Role of Gene Regulation
• CRISPR in Agriculture: Enhancing Crop Traits

Biomedical Engineering

• Tissue Engineering: Creating Organs in the Lab
• 3D Printing in Biomedical Applications
• Advances in Drug Delivery Systems
• Nanotechnology in Medicine: Theranostic Approaches
• Bioinformatics and Computational Biology in Biomedicine
• Wearable Biomedical Devices for Health Monitoring
• Stem Cell Research and Regenerative Medicine
• Precision Oncology: Tailoring Cancer Treatments
• Biomaterials for Biomedical Applications
• Biomechanics in Biomedical Engineering

Environmental Biotechnology

• Bioremediation of Polluted Environments
• Waste-to-Energy Technologies: Turning Trash into Power
• Sustainable Agriculture Practices Using Biotechnology
• Bioaugmentation in Wastewater Treatment
• Microbial Fuel Cells: Harnessing Microorganisms for Energy
• Biotechnology in Conservation Biology
• Phytoremediation: Plants as Environmental Cleanup Agents
• Aquaponics: Integration of Aquaculture and Hydroponics
• Biodiversity Monitoring Using DNA Barcoding
• Algal Biofuels: A Sustainable Energy Source

Industrial Biotechnology

• Enzyme Engineering for Industrial Applications
• Bioprocessing and Bio-manufacturing Innovations
• Industrial Applications of Microbial Biotechnology
• Bio-based Materials: Eco-friendly Alternatives
• Synthetic Biology for Industrial Processes
• Metabolic Engineering for Chemical Production
• Industrial Fermentation: Optimization and Scale-up
• Biocatalysis in Pharmaceutical Industry
• Advanced Bioprocess Monitoring and Control
• Green Chemistry: Sustainable Practices in Industry

Emerging Trends in Biotechnology

• CRISPR-Based Diagnostics: A New Era in Disease Detection
• Neurobiotechnology: Advancements in Brain-Computer Interfaces
• Advances in Nanotechnology for Healthcare
• Computational Biology: Modeling Biological Systems
• Organoids: Miniature Organs for Drug Testing
• Genome Editing in Non-Human Organisms
• Biotechnology and the Internet of Things (IoT)
• Exosome-based Therapeutics: Potential Applications
• Biohybrid Systems: Integrating Living and Artificial Components
• Metagenomics: Exploring Microbial Communities

Ethical and Social Implications

• Ethical Considerations in CRISPR-Based Gene Editing
• Privacy Concerns in Personal Genomic Data Sharing
• Biotechnology and Social Equity: Bridging the Gap
• Dual-Use Dilemmas in Biotechnological Research
• Informed Consent in Genetic Testing and Research
• Accessibility of Biotechnological Therapies: Global Perspectives
• Human Enhancement Technologies: Ethical Perspectives
• Biotechnology and Cultural Perspectives on Genetic Modification
• Social Impact Assessment of Biotechnological Interventions
• Intellectual Property Rights in Biotechnology

Computational Biology and Bioinformatics

• Machine Learning in Biomedical Data Analysis
• Network Biology: Understanding Biological Systems
• Structural Bioinformatics: Predicting Protein Structures
• Data Mining in Genomics and Proteomics
• Systems Biology Approaches in Biotechnology
• Comparative Genomics: Evolutionary Insights
• Bioinformatics Tools for Drug Discovery
• Cloud Computing in Biomedical Research
• Artificial Intelligence in Diagnostics and Treatment
• Computational Approaches to Vaccine Design

Health and Medicine

• Vaccines and Immunotherapy: Advancements in Disease Prevention
• CRISPR-Based Therapies for Genetic Disorders
• Infectious Disease Diagnostics Using Biotechnology
• Telemedicine and Biotechnology Integration
• Biotechnology in Rare Disease Research
• Gut Microbiome and Human Health
• Precision Nutrition: Personalized Diets Using Biotechnology
• Biotechnology Approaches to Combat Antibiotic Resistance
• Point-of-Care Diagnostics for Global Health
• Biotechnology in Aging Research and Longevity

Agricultural Biotechnology

• CRISPR and Gene Editing in Crop Improvement
• Precision Agriculture: Integrating Technology for Crop Management
• Biotechnology Solutions for Food Security
• RNA Interference in Pest Control
• Vertical Farming and Biotechnology
• Plant-Microbe Interactions for Sustainable Agriculture
• Biofortification: Enhancing Nutritional Content in Crops
• Smart Farming Technologies and Biotechnology
• Precision Livestock Farming Using Biotechnological Tools
• Drought-Tolerant Crops: Biotechnological Approaches

Biotechnology and Education

• Integrating Biotechnology into STEM Education
• Virtual Labs in Biotechnology Teaching
• Biotechnology Outreach Programs for Schools
• Online Courses in Biotechnology: Accessibility and Quality
• Hands-on Biotechnology Experiments for Students
• Bioethics Education in Biotechnology Programs
• Role of Internships in Biotechnology Education
• Collaborative Learning in Biotechnology Classrooms
• Biotechnology Education for Non-Science Majors
• Addressing Gender Disparities in Biotechnology Education

Funding and Policy

• Government Funding Initiatives for Biotechnology Research
• Private Sector Investment in Biotechnology Ventures
• Impact of Intellectual Property Policies on Biotechnology
• Ethical Guidelines for Biotechnological Research
• Public-Private Partnerships in Biotechnology
• Regulatory Frameworks for Gene Editing Technologies
• Biotechnology and Global Health Policy
• Biotechnology Diplomacy: International Collaboration
• Funding Challenges in Biotechnology Startups
• Role of Nonprofit Organizations in Biotechnological Research

Biotechnology and the Environment

• Biotechnology for Air Pollution Control
• Microbial Sensors for Environmental Monitoring
• Remote Sensing in Environmental Biotechnology
• Climate Change Mitigation Using Biotechnology
• Circular Economy and Biotechnological Innovations
• Marine Biotechnology for Ocean Conservation
• Bio-inspired Design for Environmental Solutions
• Ecological Restoration Using Biotechnological Approaches
• Impact of Biotechnology on Biodiversity
• Biotechnology and Sustainable Urban Development

Biosecurity and Biosafety

• Biosecurity Measures in Biotechnology Laboratories
• Dual-Use Research and Ethical Considerations
• Global Collaboration for Biosafety in Biotechnology
• Security Risks in Gene Editing Technologies
• Surveillance Technologies in Biotechnological Research
• Biosecurity Education for Biotechnology Professionals
• Risk Assessment in Biotechnology Research
• Bioethics in Biodefense Research
• Biotechnology and National Security
• Public Awareness and Biosecurity in Biotechnology

Industry Applications

• Biotechnology in the Pharmaceutical Industry
• Bioprocessing Innovations for Drug Production
• Industrial Enzymes and Their Applications
• Biotechnology in Food and Beverage Production
• Applications of Synthetic Biology in Industry
• Biotechnology in Textile Manufacturing
• Cosmetic and Personal Care Biotechnology
• Biotechnological Approaches in Renewable Energy
• Advanced Materials Production Using Biotechnology
• Biotechnology in the Automotive Industry

Miscellaneous Topics

• DNA Barcoding in Species Identification
• Bioart: The Intersection of Biology and Art
• Biotechnology in Forensic Science
• Using Biotechnology to Preserve Cultural Heritage
• Biohacking: DIY Biology and Citizen Science
• Microbiome Engineering for Human Health
• Environmental DNA (eDNA) for Biodiversity Monitoring
• Biotechnology and Astrobiology: Searching for Life Beyond Earth
• Biotechnology and Sports Science
• Biotechnology and the Future of Space Exploration

Challenges and Ethical Considerations in Biotechnology Research

As biotechnology continues to advance, it brings forth a set of challenges and ethical considerations. Biosecurity concerns, especially in the context of gene editing technologies, raise questions about the responsible use of powerful tools like CRISPR. 

Ethical implications of genetic manipulation, such as the creation of designer babies, demand careful consideration and international collaboration to establish guidelines and regulations. 

Moreover, the environmental and social impact of biotechnological interventions must be thoroughly assessed to ensure responsible and sustainable practices.

Funding and Resources for Biotechnology Research

The pursuit of biotechnology research topics requires substantial funding and resources. Government grants and funding agencies play a pivotal role in supporting research initiatives. 

Simultaneously, the private sector, including biotechnology companies and venture capitalists, invest in promising projects. Collaboration and partnerships between academia, industry, and nonprofit organizations further amplify the impact of biotechnological research.

Future Prospects of Biotechnology Research

As we look to the future, the integration of biotechnology with other scientific disciplines holds immense potential. Collaborations with fields like artificial intelligence, materials science, and robotics may lead to unprecedented breakthroughs. 

The development of innovative technologies and their application to global health and sustainability challenges will likely shape the future of biotechnology.

In conclusion, biotechnology research is a dynamic and transformative force with the potential to revolutionize multiple facets of our lives. The exploration of diverse biotechnology research topics, from genetic engineering to emerging trends like synthetic biology and nanobiotechnology, highlights the breadth of possibilities within this field. 

However, researchers must navigate challenges and ethical considerations to ensure that biotechnological advancements are used responsibly for the betterment of society. 

With continued funding, collaboration, and a commitment to ethical practices, the future of biotechnology research holds exciting promise, propelling us towards a more sustainable and technologically advanced world.

Related Posts

Step by Step Guide on The Best Way to Finance Car

The Best Way on How to Get Fund For Business to Grow it Efficiently

You are using an outdated browser. Upgrade your browser today or install Google Chrome Frame to better experience this site.

search Search Search Term search

RVC academic's paper amongst the top 10% most downloadable Microbial Biotechnology papers

 Published: 30 Apr 2020 | Last Updated: 30 Apr 2020 16:26:10

A paper written by Dr Ben Swift , published in Microbial Biotechnology, has been recognised as being among the top 10% of their most downloaded papers for the period January 2018 and December 2019.  This is a great achievement, showing how this research has generated impact.  

The paper "T he development and use of Actiphage ®   to detect viable mycobacteria from bovine tuberculosis and Johne’s disease‐infected animals "  describes the development of a method that exploits bacteriophage D29 as a lysis agent for efficient DNA extraction from low numbers of mycobacterial cells. The work was funded by Research England and also involved researchers from University of Nottingham and Moredun Research Institute.

Citation:  Swift, B M C; Meade, N; Barron, E S; Bennett, M; Perehenic, T; Hughes, V; Stevenson, K; Rees, C E D The development and use of  Actiphage ®   to detect viable mycobacteria from bovine tuberculosis and Johne’s disease‐infected animals   Microbial Biotechnology.  2019.

You may also be interested in:

New rvc research sheds light on best toys and housing to improve ferret welfare as well as those that pose serious risk.

A new study from the Royal Veterinary College (RVC), has revealed the toys and environmental …

Top of page

Subscribe to our free Newsletter! →

Home › Health & Medical News

Newly discovered ‘Holy Grail’ of proteins may lead to cancer vaccine

By StudyFinds Staff

Reviewed by Chris Melore

Research led by Robert Szabla, Western University

Aug 26, 2024

Researchers from Western University have discovered a protein that has the never-before-seen ability to stop DNA damage in its tracks. (Credit: Canadian Light Source)

LONDON, Ontario — Scientists at Western University may have just discovered the ultimate bodyguard for your DNA. They’ve found a protein with an extraordinary ability to halt DNA damage in its tracks, and it could be a game-changer for everything from cancer prevention to crop resilience.

Imagine a tiny superhero patrolling your cells , ready to swoop in and save the day whenever your DNA is in danger. That’s essentially what this newly discovered protein, called DdrC (DNA Damage Repair Protein C), does. According to the findings in Nucleic Acids Research , it comes from a fascinating bacterium with an equally fascinating name: Deinococcus radioduran s.

What makes D. radiodurans so special?

This little microbe is practically indestructible when it comes to DNA damage . It can withstand radiation levels 5,000 to 10,000 times stronger than what would kill a human cell. But that’s not all – it’s also incredibly good at repairing DNA that’s already been damaged.

“It’s as if you had a player in the NFL who plays every game without a helmet or pads,” says Robert Szabla, the study’s lead researcher, in a media release. “He’d end up with a concussion and multiple broken bones every single game, but then miraculously make a full recovery overnight in time for practice the next day.”

So, what exactly does DdrC do? Think of it as a highly specialized security system for your genetic material. It constantly scans along the DNA, looking for any signs of damage. When it finds a break, it snaps into action – literally. The protein clamps down on the damaged area, much like a mousetrap.

This swift response serves two crucial purposes:

• It stops the damage from getting worse, kind of like applying a bandage to prevent further injury.
• It acts as a beacon, signaling to the cell’s repair crew that there’s a problem that needs fixing.

What’s truly remarkable about DdrC is that it seems to work all on its own. Most proteins in our cells need to team up with others to get things done, but DdrC is like a one-protein army .

The researchers were curious to see if DdrC could lend its superpowers to other organisms. They introduced it to E. coli, a common bacterium often used in lab experiments. The results were astounding – the E. coli became over 40 times more resistant to UV radiation damage! This discovery opens up a world of possibilities.

Szabla explains that, in theory, this gene could be introduced into any organism – plants, animals, humans – and it would increase that living being’s ability to repair its DNA.

Imagine the potential applications:

• A “vaccine” against cancer by boosting our cells’ ability to prevent DNA damage
• Crops that can withstand harsh conditions brought on by climate change
• New treatments for diseases caused by DNA damage

‘The Holy Grail in biotechnology’

“The ability to rearrange and edit and manipulate DNA in specific ways is the holy grail in biotechnology ,” says Szabla. “What if you had a scanning system such as DdrC which patrolled your cells and neutralized damage when it happened? This might form the basis of a potential cancer vaccine.”

However, DdrC might just be the tip of the iceberg. The researchers believe there could be hundreds more useful proteins waiting to be discovered in D. radiodurans. Each one could potentially unlock new ways to protect and repair DNA, leading to breakthroughs we can’t even imagine yet.

This groundbreaking research wouldn’t have been possible without some seriously high-tech equipment. The team used the Canadian Light Source (CLS) at the University of Saskatchewan, which Szabla describes as “the most powerful X-ray source in Canada.”

This advanced technology allowed the scientists to determine the 3D shape of the DdrC protein. From there, they could work backwards to understand how it performs its DNA-protecting “superpower.”

While the discovery of DdrC is exciting, it’s important to remember that scientists are still in the early stages of understanding its full potential. There’s a lot more work to be done before we might see applications in medicine or agriculture.

“DdrC is just one out of hundreds of potentially useful proteins in this bacterium. The next step is to prod further, look at what else this cell uses to fix its own genome – because we’re sure to find many more tools where we have no idea how they work or how they’re going to be useful until we look,” Szabla concludes.

Paper Summary

Methodology.

To understand how DdrC works, the researchers conducted a series of experiments that included crystallography to study the protein’s structure, and various biochemical assays to test its ability to bind and compact DNA. The crystallography revealed the unusual asymmetric structure of DdrC, while the biochemical assays showed how DdrC interacts with DNA to stabilize and repair it.

In one set of experiments, the researchers used different types of DNA, including linear DNA with single and double breaks, to see how DdrC would respond. They found that DdrC was most effective at compacting DNA when there were multiple breaks, confirming that the protein’s compaction ability is linked to the extent of DNA damage.

Key Results

DdrC was shown to bind to DNA at the site of breaks and induce compaction by bringing the broken ends closer together. This compaction was most pronounced when there were multiple breaks, and it led to the circularization of linear DNA. This circularization is a crucial step in the DNA repair process, as it allows the broken ends to be rejoined more easily.

The researchers also found that DdrC’s ability to compact DNA was dependent on its asymmetrical structure. Without this asymmetry, the protein could not bind to multiple breaks simultaneously, and the DNA could not be compacted or circularized effectively.

Study Limitations

While the study provides important insights into how DdrC repairs DNA, there are still many questions to be answered. For example, the exact mechanism by which DdrC recognizes DNA breaks is not fully understood. Additionally, while the protein’s ability to compact DNA is clear, the researchers were not able to determine whether DdrC actively supercoils the DNA or simply induces a similar structure.

Further research will be necessary to explore these questions, as well as to determine whether similar proteins exist in other organisms. The findings also raise the possibility that DdrC could be used in biotechnological applications, such as developing new methods for repairing damaged DNA in human cells or protecting DNA during long-term space missions.

Discussion & Takeaways

The discovery of DdrC’s unique mechanism for repairing DNA is a significant advancement in our understanding of how D. radiodurans survives in extreme conditions. By compacting and stabilizing DNA, DdrC ensures that the bacterium’s genetic material remains intact, even in the face of severe damage. This ability could have important implications for a variety of fields, including medicine, biotechnology, and space exploration.

One of the key takeaways from this study is the importance of protein structure in DNA repair. DdrC’s asymmetry allows it to perform a function that would be impossible for a symmetric protein, highlighting the role that protein structure plays in biological processes.

Funding & Disclosures

This research was supported by funding from the Natural Sciences and Engineering Research Council of Canada. The authors declare no competing interests related to this study.

About StudyFinds Staff

StudyFinds sets out to find new research that speaks to mass audiences — without all the scientific jargon. The stories we publish are digestible, summarized versions of research that are intended to inform the reader as well as stir civil, educated debate. StudyFinds Staff articles are AI assisted, but always thoroughly reviewed and edited by a Study Finds staff member. Read our AI Policy for more information.

Our Editorial Process

StudyFinds publishes digestible, agenda-free, transparent research summaries that are intended to inform the reader as well as stir civil, educated debate. We do not agree nor disagree with any of the studies we post, rather, we encourage our readers to debate the veracity of the findings themselves. All articles published on StudyFinds are vetted by our editors prior to publication and include links back to the source or corresponding journal article, if possible.

Our Editorial Team

Editor-in-Chief

Chris Melore

Sophia Naughton

Associate Editor

Related Content

How workplace rudeness is killing productivity and endangering lives

August 28, 2024

5 Best Keurig K-Cups, According To Coffee Lovers

Your voice may reveal if you have Type 2 diabetes

Leave a reply cancel reply.

©2024 Study Finds. All rights reserved. Privacy Policy • Disclosure Policy • Do Not Sell My Personal Information

Academia.edu no longer supports Internet Explorer.

To browse Academia.edu and the wider internet faster and more securely, please take a few seconds to  upgrade your browser .

Enter the email address you signed up with and we'll email you a reset link.

• We're Hiring!
• Help Center

Current research in biotechnology: Exploring the biotech forefront

2019, Current Research in Biotechnology

Biotechnology is an evolving research field that covers a broad range of topics. Here we aimed to evaluate the latest research literature, to identify prominent research themes, major contributors in terms of institutions, countries/re-gions, and journals. The Web of Science Core Collection online database was searched to retrieve biotechnology articles published since 2017. In total, 12,351 publications were identified and analyzed. Over 8500 institutions contributed to these biotechnology publications, with the top 5 most productive ones scattered over France, China, the United States of America, Spain, and Brazil. Over 140 countries/regions contributed to the biotechnology research literature, led by the United States of America, China, Germany, Brazil, and India. Journal of Bioscience and Bioengineer-ing was the most productive journal in terms of number of publications. Metabolic engineering was among the most prevalent biotechnology study themes, and Escherichia coli and Saccharomyces cerevisiae were frequently used in biotechnology investigations, including the biosynthesis of useful biomolecules, such as myo-inositol (vitamin B8), mono-terpenes, adipic acid, astaxanthin, and ethanol. Nanoparticles and nanotechnology were identified too as emerging biotechnology research themes of great significance. Biotechnology continues to evolve and will remain a major driver of societal innovation and development.

Related Papers

ASHOK PANDEY

Applied Biochemistry and Microbiology - APPL BIOCHEM MICROBIOL-ENGL T

Abdullahi Hassan

Current Developments in Biotechnology and Bioengineering

saumya khare

ADURI PRAKASH REDDY

Biolife 2(3):905-916

Shabir Wani , Saroj Sah

Scientists worldwide are continuing to discover unique properties of every day materials at the submicrometer scale. This size domain is better known as nanometer domain and technology concerned with this is known as nanotechnology that involves working with particles at nano level. One of the most important emerging fields of science in this centur y is Nanotechnology. It deals with designing, construction, investigation and utilization of systems at the nanoscale. The interface between nanotechnology and biotechnology is nanobiotechnology, which exploits nanotechnology and biotechnology to analyse a nd create nanobiosystems to meet a wide variety of challenges and develops a wide range of applications. Biotechnology gives us a way to understand biological system and to utilize our knowledge for industrial manufacturing. Nanotechnology has great potent ial and by the help of its application it can enhance the quality of life through in various fields like agriculture and the food system. Around the world, it has become the future of any nation. Important tools used in nanotechnology and application of nanobiotechnology in agriculture sector will be discussed in this review.

Revista Peruana de Biología

Gretty K Villena Chavez

Rahul J Desale

Anand Kumar Thakur

Jay D Keasling

theppanya charoenrat

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

RELATED PAPERS

Scripown publication, New Delhi

Arulmozhi Ranjan

Yusuf Deeni , MICHELE MAFFIA

Hwa A. Lim, "Biotechnology - Past, present and future", Symbiosis, October 2004, pp. 31-34.

Hwa A . Lim

World Journal of Pharmaceutical Sciences

Nanobiotechnology in Food: Concepts, Applications and Perspectives

Zahra Sayyar

Journal of the National Science Foundation of Sri Lanka

Ranjan Ramasamy

Rashid Amin

Martin Philbert

melissa Tielke

book chapter

Abrar Hussain

Biotechnology Journal

Mohamad Faizal Ibrahim

Wei-Seng Ho

BioEnergy Research

International Journal of Current Microbiology and Applied Sciences

Ranjeet Verma

Stylianos Anestis

Food Technology and Biotechnology

Karl Friedl

G.Ali Mansoori

anchal srivastava

RELATED TOPICS

•   We're Hiring!
•   Help Center
• Find new research papers in:
• Health Sciences
• Earth Sciences
• Cognitive Science
• Mathematics
• Computer Science
• Academia ©2024

• Interesting
• Scholarships
• UGC-CARE Journals

Top 50 Emerging Research Topics in Biotechnology

Trending Research Topics in Biotechnology

Biotechnology is a dynamic field that continuously shapes our world, enabling innovation, breakthroughs, and solutions to various challenges. As we move into the future, numerous emerging research areas promise to revolutionize healthcare, agriculture, environmental sustainability, and more. The top 50 emerging research topics in biotechnology are presented in this article.

1. Gene Editing and Genomic Engineering

a. CRISPR and Gene Editing

Precision Medicine : Developing targeted therapies for various diseases using CRISPR/Cas9 and other gene-editing tools.

Ethical Implications : Exploring and addressing ethical concerns surrounding CRISPR use in human embryos and germline editing.

Agricultural Advancements : Enhancing crop resistance and nutritional content through gene editing of improved farm outcomes.

Gene Drive Technology : Investigating the potential of gene drive technology to control vector-borne diseases like malaria and dengue fever.

Regulatory Frameworks : Establishing global regulations for responsible gene editing applications in different fields.

b. Synthetic Biology

Bioengineering Microbes : Creating engineered microorganisms for sustainable production of fuels, pharmaceuticals, and materials.

Designer Organisms : Designing novel organisms with specific functionalities for environmental remediation or industrial processes.

Cell-Free Systems : Developing cell-free systems for various applications, including drug production and biosensors.

Biosecurity Measures : Addressing concerns regarding the potential misuse of synthetic biology for bioterrorism.

Standardization and Automation : Standardizing synthetic biology methodologies and automating processes to streamline production.

2. Personalized Medicine and Pharmacogenomics

a. Precision Medicine

Individualized Treatment : Tailoring medical treatment based on a person’s genetic makeup and environmental factors.

Cancer Therapy : Advancing targeted cancer therapies based on the genetic profile of tumors and patients.

Data Analytics : Implementing big data and AI for comprehensive analysis of genomic and clinical data to improve treatment outcomes.

Clinical Implementation : Integrating genetic testing into routine clinical practice for personalized healthcare.

Public Health and Policy : Addressing the challenges of integrating personalized medicine into public health policies and practices.

b. Pharmacogenomics

Drug Development : Optimizing drug development based on individual genetic variations to improve efficacy and reduce side effects.

Adverse Drug Reactions : Understanding genetic predispositions to adverse drug reactions and minimizing risks.

Dosing Optimization : Tailoring drug dosage based on an individual’s genetic profile for better treatment outcomes.

Economic Implications : Assessing the economic impact of pharmacogenomics on healthcare systems.

Education and Training : Educating healthcare professionals on integrating pharmacogenomic data into clinical practice.

3. Nanobiotechnology and Nanomedicine

a. Nanoparticles in Medicine

Drug Delivery Systems : Developing targeted drug delivery systems using nanoparticles for enhanced efficacy and reduced side effects.

Theranostics : Integrating diagnostics and therapeutics through nanomaterials for personalized medicine.

Imaging Techniques : Advancing imaging technologies using nanoparticles for better resolution and early disease detection.

Biocompatibility and Safety : Ensuring the safety and biocompatibility of nanoparticles used in medicine.

Regulatory Frameworks : Establishing regulations for the use of nanomaterials in medical applications.

b. Nanosensors and Diagnostics

Point-of-Care Diagnostics : Developing portable and rapid diagnostic tools for various diseases using nanotechnology.

Biosensors : Creating highly sensitive biosensors for detecting biomarkers and pathogens in healthcare and environmental monitoring.

Wearable Health Monitors : Integrating nanosensors into wearable devices for continuous health monitoring.

Challenges and Limitations : Addressing challenges in scalability, reproducibility, and cost-effectiveness of nanosensor technologies.

Future Applications : Exploring potential applications of nanosensors beyond healthcare, such as environmental monitoring and food safety.

4. Immunotherapy and Vaccine Development

a. Cancer Immunotherapy

Immune Checkpoint Inhibitors : Enhancing the efficacy of immune checkpoint inhibitors and understanding resistance mechanisms.

CAR-T Cell Therapy : Improving CAR-T cell therapy for a wider range of cancers and reducing associated side effects.

Combination Therapies : Investigating combination therapies for better outcomes in cancer treatment.

Biomarkers and Predictive Models : Identifying predictive biomarkers for immunotherapy response.

Long-Term Effects : Studying the long-term effects and immune-related adverse events of immunotherapies.

b. Vaccine Technology

mRNA Vaccines : Advancing mRNA vaccine technology for various infectious diseases and cancers.

Universal Vaccines : Developing universal vaccines targeting multiple strains of viruses and bacteria.

Vaccine Delivery Systems : Innovating vaccine delivery methods for improved stability and efficacy.

Vaccine Hesitancy : Addressing vaccine hesitancy through education, communication, and community engagement.

Pandemic Preparedness : Developing strategies for rapid vaccine development and deployment during global health crises.

5. Environmental Biotechnology and Sustainability

a. Bioremediation and Bioenergy

Biodegradation Techniques : Using biotechnology to enhance the degradation of pollutants and contaminants in the environment.

Biofuels : Developing sustainable biofuel production methods from renewable resources.

Microbial Fuel Cells : Harnessing microbial fuel cells for energy generation from organic waste.

Circular Economy : Integrating biotechnological solutions for a circular economy and waste management.

Ecosystem Restoration : Using biotechnology for the restoration of ecosystems affected by pollution and climate change.

b. Agricultural Biotechnology

Genetically Modified Crops : Advancing genetically modified crops for improved yields, pest resistance, and nutritional content.

Precision Agriculture : Implementing biotechnological tools for precise and sustainable farming practices.

Climate-Resilient Crops : Developing crops resilient to climate change-induced stresses.

Micro-biome Applications : Leveraging the plant micro-biome for enhanced crop health and productivity.

Consumer Acceptance and Regulation : Addressing consumer concerns and regulatory challenges related to genetically modified crops.

The field of biotechnology is a beacon of hope for addressing the challenges of our time, offering promising solutions for healthcare, sustainability, and more. As researchers explore these emerging topics, the potential for ground-breaking discoveries and transformative applications is immense.

I hope this article will help you to find the top research topics in biotechnology that promise to revolutionize healthcare, agriculture, environmental sustainability, and more.

• Drug delivery
• Environmental Engineering
• Gene editing
• Genomic Engineering
• Molecular Biology
• Nanoparticles
• Pharmacogenomics
• Research Ideas
• Synthetic biology

What is a PhD? A Comprehensive Guide for Indian Scientists and Aspiring Researchers

Abstract template for research paper, top 50 research institutions in india: nirf rankings 2024, most popular, the nippon foundation fellowship programme 2025, fellowships in india 2024 -comprehensive guide, agi in research: unraveling the future of artificial intelligence, working sci-hub proxy links 2024: access research papers easily, 10 types of plagiarism – every academic writer should know – updated, the harsh reality: why revoked graduate degrees aren’t easily reclaimed, top 35 scopus indexed journals in english literature, best for you, 24 best online plagiarism checker free – 2024, popular posts, newly accepted scopus indexed journals june 2024, top 10 scopus indexed agronomy and crop science journals, popular category.

• POSTDOC 317
• Interesting 257
• Journals 235
• Fellowship 134
• Research Methodology 102
• All Scopus Indexed Journals 93

Mail Subscription

iLovePhD is a research education website to know updated research-related information. It helps researchers to find top journals for publishing research articles and get an easy manual for research tools. The main aim of this website is to help Ph.D. scholars who are working in various domains to get more valuable ideas to carry out their research. Learn the current groundbreaking research activities around the world, love the process of getting a Ph.D.

Contact us: [email protected]

Google News

Copyright © 2024 iLovePhD. All rights reserved

• Artificial intelligence

Top 50 Research Topics in Biotechnology

Table of Contents

Biotechnology

Research in biotechnology can helps in bringing massive changes in humankind and lead to a better life. In the last few years, there have been so many leaps, and paces of innovations as scientists worldwide worked to develop and produce novel mRNA vaccinations and brought some significant developments in biotechnology. During this period, they also faced many challenges. Disturbances in the supply chain and the pandemic significantly impacted biotech labs and researchers, forcing lab managers to become ingenious in buying lab supplies, planning experiments, and using technology for maintaining research schedules.

The Biotech Research Technique is changing

How research is being done is changing, as also how scientists are conducting it. Affected by both B2C eCommerce and growing independence in remote and cloud-dependent working, most of the biotechnology labs are going through some digital transformations. This implies more software, automation, and AI in the biotech lab, along with some latest digital procurement plans and integrated systems for various lab operations.

Look at some of the top trends in biotech research and recent Biotechnology Topics that are bringing massive changes in this vast world of science, resulting in some innovation in life sciences and biotechnology ideas .

We share different job or exam notices on Labmonk Notice Board . You can search “ Labmonk Notice Board ” on google search to check out latest jobs of your field.

Leave a Comment Cancel reply

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

• View all journals

Synthetic biology articles from across Nature Portfolio

Synthetic biology is the design and construction of new biological parts, devices, and systems, and the re-design of existing, natural biological systems for useful purposes.

Latest Research and Reviews

Fate induction in CD8 CAR T cells through asymmetric cell division

We show that target-induced proximity labelling enables isolation of first-division CD8 chimeric antigen receptor T cells that asymmetrically distribute their surface proteome and transcriptome, resulting in distinct phenotypic, metabolic and functional profiles in proximal and distal daughter cells.

• Casey S. Lee
• Christoph T. Ellebrecht

Temporally controlled multistep division of DNA droplets for dynamic artificial cells

Controlling the dynamics of synthetic liquid-liquid phase separation droplets is essential for various bioinspired systems. Here, authors demonstrate temporally-controlled multi-step division of DNA-based liquid droplets, and develop a molecular computation system to compare miRNA concentrations.

• Tomoya Maruyama
• Masahiro Takinoue

Massively parallel measurement of protein–protein interactions by sequencing using MP3-seq

A method called massively parallel PPI measurement by sequencing (MP3-seq) is developed for measuring protein–protein interactions at scale. MP3-seq uses DNA barcodes that are associated with specific protein pairs and provides a quantitative measure of interaction strength. Interactions between rationally designed heterodimers and elements conferring interaction specificity were investigated using MP3-seq.

• Alexandr Baryshev
• Alyssa La Fleur
• Georg Seelig

From resonance to chaos by modulating spatiotemporal patterns through a synthetic optogenetic oscillator

Oscillations are a recurrent phenomenon in biological systems across scales, but deciphering their fundamental principles is very challenging. Here the authors construct a synthetic oscillator in bacteria that can be controlled by light and show that different light conditions can generate complex dynamics that are transformed into distinct spatial ring patterns in bacterial colonies.

• Jung Hun Park
• Gábor Holló
• Yolanda Schaerli

Degradable living plastics programmed by engineered spores

Spores harboring the gene circuit for the secretory expression of Burkholderia cepacia lipase were processed with poly(caprolactone) pellets to manufacture living plastics. Spore incorporation did not compromise the properties of the materials. Damage to the plastic surface and triggering of germinated cells caused secretion of the lipase, leading to depolymerization.

• Chenwang Tang
• Zhuojun Dai

Altering traits and fates of wild populations with Mendelian DNA sequence modifying Allele Sails

Population-scale genome modification can alter the composition or fate of wild populations. Here the authors introduce Allele Sails as a method for spreading genetic changes throughout a population.

• Michelle L. Johnson
• Bruce A. Hay
• Maciej Maselko

News and Comment

Proximity-triggered protein trans -splicing.

• Arunima Singh

Harnessing a brain parasite as a tool for delivery of therapeutics to the brain

Toxoplasma gondii , a eukaryotic brain parasite that infects one in three people worldwide, was engineered to deliver therapeutics to neurons in the mouse brain. This technology opens the door to deliver multiple large proteins that have been undeliverable with previous approaches. Further development, such as vector attenuation, will be necessary for many applications.

Genetically engineered synthetic cells activate cargo release upon temperature shift

We combine RNA thermometer genetic switches, cell-free protein expression and synthetic cell design to create cell-sized systems that can initiate the synthesis of soluble proteins at defined temperatures. We show that when these switches are used to control the expression of a pore-forming membrane protein, temperature-controlled cargo release is achieved, with potential future applications in biomedicine.

Quantitative synthetic biology

Synthetic biology faces major challenges in the rational design of complex living systems, necessitating a quantitative understanding of the principles that guide the emergence of functions from biological building blocks. Here, we propose quantitative synthetic biology as a new research paradigm, integrating quantitative biology, systems biology and synthetic biology.

• Guoping Zhao

Autotrophic yeast

Yeast is a widely used cell factory for the conversion of sugar into fuels, chemicals and pharmaceuticals. Establishing yeast as being autotrophic can enable it to grow solely on CO 2 and light, and hereby yeast can be used as a wider platform for transition to a sustainable society.

• Jens Nielsen

Enzymatic synthesis of RNA oligonucleotides

Research on enzymatic RNA synthesis has long been eclipsed by work on DNA—but a new method provides a leap forward for RNA.

• Marcel Hollenstein

Quick links

• Explore articles by subject
• Guide to authors
• Editorial policies

Biotechnology Research Paper Topics

This collection of biotechnology research paper topics provides the list of 10 potential topics for research papers and overviews the history of biotechnology.

Academic Writing, Editing, Proofreading, And Problem Solving Services

Get 10% off with 24start discount code, 1. animal breeding: genetic methods.

Modern animal breeding relies on scientific methods to control production of domesticated animals, both livestock and pets, which exhibit desired physical and behavioral traits. Genetic technology aids animal breeders to attain nutritional, medical, recreational, and fashion standards demanded by consumers for animal products including meat, milk, eggs, leather, wool, and pharmaceuticals. Animals are also genetically designed to meet labor and sporting requirements for speed and endurance, conformation and beauty ideals to win show competitions, and intelligence levels to perform obediently at tasks such as herding, hunting, and tracking. By the late twentieth century, genetics and mathematical models were appropriated to identify the potential of immature animals. DNA markers indicate how young animals will mature, saving breeders money by not investing in animals lacking genetic promise. Scientists also successfully transplanted sperm-producing stem cells with the goal of restoring fertility to barren breeding animals. At the National Animal Disease Center in Ames, Iowa, researchers created a gene-based test, which uses a cloned gene of the organism that causes Johne’s disease in cattle in order to detect that disease to avert epidemics. Researchers also began mapping the dog genome and developing molecular techniques to evaluate canine chromosomes in the Quantitative Trait Loci (QTL). Bioinformatics incorporates computers to analyze genetic material. Some tests were developed to diagnose many of several hundred genetic canine diseases including hip dysplasia and progressive retinal atrophy (PRA). A few breed organizations modified standards to discourage breeding of genetically flawed animals and promote heterozygosity.

2. Antibacterial Chemotherapy

In the early years of the twentieth century, the search for agents that would be effective against internal infections proceeded along two main routes. The first was a search for naturally occurring substances that were effective against microorganisms (antibiosis). The second was a search for chemicals that would have the same effect (chemotherapy). Despite the success of penicillin in the 1940s, the major early advances in the treatment of infection occurred not through antibiosis but through chemotherapy. The principle behind chemotherapy was that there was a relationship between chemical structure and pharmacological action. The founder of this concept was Paul Erhlich (1854–1915). An early success came in 1905 when atoxyl (an organic arsenic compound) was shown to destroy trypanosomes, the microbes that caused sleeping sickness. Unfortunately, atoxyl also damaged the optic nerve. Subsequently, Erhlich and his co-workers synthesized and tested hundreds of related arsenic compounds. Ehrlich was a co-recipient (with Ilya Ilyich Mechnikov) of the Nobel Prize in medicine in 1908 for his work on immunity. Success in discovering a range of effective antibacterial drugs had three important consequences: it brought a range of important diseases under control for the first time; it provided a tremendous stimulus to research workers and opened up new avenues of research; and in the resulting commercial optimism, it led to heavy postwar investment in the pharmaceutical industry. The therapeutic revolution had begun.

3. Artificial Insemination and in Vitro Fertilization

Artificial insemination (AI) involves the extraction and collection of semen together with techniques for depositing semen in the uterus in order to achieve successful fertilization and pregnancy. Throughout the twentieth century, the approach has offered animal breeders the advantage of being able to utilize the best available breeding stock and at the correct time within the female reproductive cycle, but without the limitations of having the animals in the same location. AI has been applied most intensively within the dairy and beef cattle industries and to a lesser extent horse breeding and numerous other domesticated species.

Many of the techniques involved in artificial insemination would lay the foundation for in vitro fertilization (IVF) in the latter half of the twentieth century. IVF refers to the group of technologies that allow fertilization to take place outside the body involving the retrieval of ova or eggs from the female and sperm from the male, which are then combined in artificial, or ‘‘test tube,’’ conditions leading to fertilization. The fertilized eggs then continue to develop for several days ‘‘in culture’’ until being transferred to the female recipient to continue developing within the uterus.

4. Biopolymers

Biopolymers are natural polymers, long-chained molecules (macromolecules) consisting mostly of a repeated composition of building blocks or monomers that are formed and utilized by living organisms. Each group of biopolymers is composed of different building blocks, for example chains of sugar molecules form starch (a polysaccharide), chains of amino acids form proteins and peptides, and chains of nucleic acid form DNA and RNA (polynucleotides). Biopolymers can form gels, fibers, coatings, and films depending on the specific polymer, and serve a variety of critical functions for cells and organisms. Proteins including collagens, keratins, silks, tubulins, and actin usually form structural composites or scaffolding, or protective materials in biological systems (e.g., spider silk). Polysaccharides function in molecular recognition at cell membrane surfaces, form capsular barrier layers around cells, act as emulsifiers and adhesives, and serve as skeletal or architectural materials in plants. In many cases these polymers occur in combination with proteins to form novel composite structures such as invertebrate exoskeletons or microbial cell walls, or with lignin in the case of plant cell walls.

The use of the word ‘‘cloning’’ is fraught with confusion and inconsistency, and it is important at the outset of this discussion to offer definitional clarification. For instance, in the 1997 article by Ian Wilmut and colleagues announcing the birth of the first cloned adult vertebrate (a ewe, Dolly the sheep) from somatic cell nuclear transfer, the word clone or cloning was never used, and yet the announcement raised considerable disquiet about the prospect of cloned human beings. In a desire to avoid potentially negative forms of language, many prefer to substitute ‘‘cell expansion techniques’’ or ‘‘therapeutic cloning’’ for cloning. Cloning has been known for centuries as a horticultural propagation method: for example, plants multiplied by grafting, budding, or cuttings do not differ genetically from the original plant. The term clone entered more common usage as a result of a speech in 1963 by J.B.S. Haldane based on his paper, ‘‘Biological possibilities for the human species of the next ten-thousand years.’’ Notwithstanding these notes of caution, we can refer to a number of processes as cloning. At the close of the twentieth century, such techniques had not yet progressed to the ability to bring a cloned human to full development; however, the ability to clone cells from an adult human has potential to treat diseases. International policymaking in the late 1990s sought to distinguish between the different end uses for somatic cell nuclear transfer resulting in the widespread adoption of the distinction between ‘‘reproductive’’ and ‘‘therapeutic’’ cloning. The function of the distinction has been to permit the use (in some countries) of the technique to generate potentially beneficial therapeutic applications from embryonic stem cell technology whilst prohibiting its use in human reproduction. In therapeutic applications, nuclear transfer from a patient’s cells into an enucleated ovum is used to create genetically identical embryos that would be grown in vitro but not be allowed to continue developing to become a human being. The resulting cloned embryos could be used as a source from which to produce stem cells that can then be induced to specialize into the specific type of tissue required by the patient (such as skin for burns victims, brain neuron cells for Parkinson’s disease sufferers, or pancreatic cells for diabetics). The rationale is that because the original nuclear material is derived from a patient’s adult tissue, the risks of rejection of such cells by the immune system are reduced.

6. Gene Therapy

In 1971, Australian Nobel laureate Sir F. MacFarlane Burnet thought that gene therapy (introducing genes into body tissue, usually to treat an inherited genetic disorder) looked more and more like a case of the emperor’s new clothes. Ethical issues aside, he believed that practical considerations forestalled possibilities for any beneficial gene strategy, then or probably ever. Bluntly, he wrote: ‘‘little further advance can be expected from laboratory science in the handling of ‘intrinsic’ types of disability and disease.’’ Joshua Lederberg and Edward Tatum, 1958 Nobel laureates, theorized in the 1960s that genes might be altered or replaced using viral vectors to treat human diseases. Stanfield Rogers, working from the Oak Ridge National Laboratory in 1970, had tried but failed to cure argininemia (a genetic disorder of the urea cycle that causes neurological damage in the form of mental retardation, seizures, and eventually death) in two German girls using Swope papilloma virus. Martin Cline at the University of California in Los Angeles, made the second failed attempt a decade later. He tried to correct the bone marrow cells of two beta-thalassemia patients, one in Israel and the other in Italy. What Cline’s failure revealed, however, was that many researchers who condemned his trial as unethical were by then working toward similar goals and targeting different diseases with various delivery methods. While Burnet’s pessimism finally proved to be wrong, progress in gene therapy was much slower than antibiotic or anticancer chemotherapy developments over the same period of time. While gene therapy had limited success, it nevertheless remained an active area for research, particularly because the Human Genome Project, begun in 1990, had resulted in a ‘‘rough draft’’ of all human genes by 2001, and was completed in 2003. Gene mapping created the means for analyzing the expression patterns of hundreds of genes involved in biological pathways and for identifying single nucleotide polymorphisms (SNPs) that have diagnostic and therapeutic potential for treating specific diseases in individuals. In the future, gene therapies may prove effective at protecting patients from adverse drug reactions or changing the biochemical nature of a person’s disease. They may also target blood vessel formation in order to prevent heart disease or blindness due to macular degeneration or diabetic retinopathy. One of the oldest ideas for use of gene therapy is to produce anticancer vaccines. One method involves inserting a granulocyte-macrophage colony-stimulating factor gene into prostate tumor cells removed in surgery. The cells then are irradiated to prevent any further cancer and injected back into the same patient to initiate an immune response against any remaining metastases. Whether or not such developments become a major treatment modality, no one now believes, as MacFarland Burnet did in 1970, that gene therapy science has reached an end in its potential to advance health.

7. Genetic Engineering

The term ‘‘genetic engineering’’ describes molecular biology techniques that allow geneticists to analyze and manipulate deoxyribonucleic acid (DNA). At the close of the twentieth century, genetic engineering promised to revolutionize many industries, including microbial biotechnology, agriculture, and medicine. It also sparked controversy over potential health and ecological hazards due to the unprecedented ability to bypass traditional biological reproduction.

For centuries, if not millennia, techniques have been employed to alter the genetic characteristics of animals and plants to enhance specifically desired traits. In a great many cases, breeds with which we are most familiar bear little resemblance to the wild varieties from which they are derived. Canine breeds, for instance, have been selectively tailored to changing esthetic tastes over many years, altering their appearance, behavior and temperament. Many of the species used in farming reflect long-term alterations to enhance meat, milk, and fleece yields. Likewise, in the case of agricultural varieties, hybridization and selective breeding have resulted in crops that are adapted to specific production conditions and regional demands. Genetic engineering differs from these traditional methods of plant and animal breeding in some very important respects. First, genes from one organism can be extracted and recombined with those of another (using recombinant DNA, or rDNA, technology) without either organism having to be of the same species. Second, removing the requirement for species reproductive compatibility, new genetic combinations can be produced in a much more highly accelerated way than before. Since the development of the first rDNA organism by Stanley Cohen and Herbert Boyer in 1973, a number of techniques have been found to produce highly novel products derived from transgenic plants and animals.

At the same time, there has been an ongoing and ferocious political debate over the environmental and health risks to humans of genetically altered species. The rise of genetic engineering may be characterized by developments during the last three decades of the twentieth century.

8. Genetic Screening and Testing

The menu of genetic screening and testing technologies now available in most developed countries increased rapidly in the closing years of the twentieth century. These technologies emerged within the context of rapidly changing social and legal contexts with regard to the medicalization of pregnancy and birth and the legalization of abortion. The earliest genetic screening tests detected inborn errors of metabolism and sex-linked disorders. Technological innovations in genomic mapping and DNA sequencing, together with an explosion in research on the genetic basis of disease which culminated in the Human Genome Project (HGP), led to a range of genetic screening and testing for diseases traditionally recognized as genetic in origin and for susceptibility to more common diseases such as certain types of familial cancer, cardiac conditions, and neurological disorders among others. Tests were also useful for forensic, or nonmedical, purposes. Genetic screening techniques are now available in conjunction with in vitro fertilization and other types of reproductive technologies, allowing the screening of fertilized embryos for certain genetic mutations before selection for implantation. At present selection is purely on disease grounds and selection for other traits (e.g., for eye or hair color, intelligence, height) cannot yet be done, though there are concerns for eugenics and ‘‘designer babies.’’ Screening is available for an increasing number of metabolic diseases through tandem mass spectrometry, which uses less blood per test, allows testing for many conditions simultaneously, and has a very low false-positive rate as compared to conventional Guthrie testing. Finally, genetic technologies are being used in the judicial domain for determination of paternity, often associated with child support claims, and for forensic purposes in cases where DNA material is available for testing.

9. Plant Breeding: Genetic Methods

The cultivation of plants is the world’s oldest biotechnology. We have continually tried to produce improved varieties while increasing yield, features to aid cultivation and harvesting, disease, and pest resistance, or crop qualities such as longer postharvest storage life and improved taste or nutritional value. Early changes resulted from random crosspollination, rudimentary grafting, or spontaneous genetic change. For centuries, man kept the seed from the plants with improved characteristics to plant the following season’s crop. The pioneering work of Gregor Mendel and his development of the basic laws of heredity showed for other first time that some of the processes of heredity could be altered by experimental means. The genetic analysis of bacterial (prokaryote) genes and techniques for analysis of the higher (eukaryotic) organisms such as plants developed in parallel streams, but the rediscovery of Mendel’s work in 1900 fueled a burst of activity on understanding the role of genes in inheritance. The knowledge that genes are linked along the chromosome thereby allowed mapping of genes (transduction analysis, conjugation analysis, and transformation analysis). The power of genetics to produce a desirable plant was established, and it was appreciated that controlled breeding (test crosses and back crosses) and careful analysis of the progeny could distinguish traits that were dominant or recessive, and establish pure breeding lines. Traditional horticultural techniques of artificial self-pollination and cross-pollination were also used to produce hybrids. In the 1930s the Russian Nikolai Vavilov recognized the value of genetic diversity in domesticated crop plants and their wild relatives to crop improvement, and collected seeds from the wild to study total genetic diversity and use these in breeding programs. The impact of scientific crop breeding was established by the ‘‘Green revolution’’ of the 1960s, when new wheat varieties with higher yields were developed by careful crop breeding. ‘‘Mutation breeding’’— inducing mutations by exposing seeds to x-rays or chemicals such as sodium azide, accelerated after World War II. It was also discovered that plant cells and tissues grown in tissue culture would mutate rapidly. In the 1970s, haploid breeding, which involves producing plants from two identical sets of chromosomes, was extensively used to create new cultivars. In the twenty-first century, haploid breeding could speed up plant breeding by shortening the breeding cycle.

10. Tissue Culturing

The technique of tissue or cell culture, which relates to the growth of tissue or cells within a laboratory setting, underlies a phenomenal proportion of biomedical research. Though it has roots in the late nineteenth century, when numerous scientists tried to grow samples in alien environments, cell culture is credited as truly beginning with the first concrete evidence of successful growth in vitro, demonstrated by Johns Hopkins University embryologist Ross Harrison in 1907. Harrison took sections of spinal cord from a frog embryo, placed them on a glass cover slip and bathed the tissue in a nutrient media. The results of the experiment were startling—for the first time scientists visualized actual nerve growth as it would happen in a living organism—and many other scientists across the U.S. and Europe took up culture techniques. Rather unwittingly, for he was merely trying to settle a professional dispute regarding the origin of nerve fibers, Harrison fashioned a research tool that has since been designated by many as the greatest advance in medical science since the invention of the microscope.

From the 1980s, cell culture has once again been brought to the forefront of cancer research in the isolation and identification of numerous cancer causing oncogenes. In addition, cell culturing continues to play a crucial role in fields such as cytology, embryology, radiology, and molecular genetics. In the future, its relevance to direct clinical treatment might be further increased by the growth in culture of stem cells and tissue replacement therapies that can be tailored for a particular individual. Indeed, as cell culture approaches its centenary, it appears that its importance to scientific, medical, and commercial research the world over will only increase in the twenty-first century.

History of Biotechnology

Biotechnology grew out of the technology of fermentation, which was called zymotechnology. This was different from the ancient craft of brewing because of its thought-out relationships to science. These were most famously conceptualized by the Prussian chemist Georg Ernst Stahl (1659–1734) in his 1697 treatise Zymotechnia Fundamentalis, in which he introduced the term zymotechnology. Carl Balling, long-serving professor in Prague, the world center of brewing, drew on the work of Stahl when he published his Bericht uber die Fortschritte der zymotechnische Wissenschaften und Gewerbe (Account of the Progress of the Zymotechnic Sciences and Arts) in the mid-nineteenth century. He used the idea of zymotechnics to compete with his German contemporary Justus Liebig for whom chemistry was the underpinning of all processes.

By the end of the nineteenth century, there were attempts to develop a new scientific study of fermentation. It was an aspect of the ‘‘second’’ Industrial Revolution during the period from 1870 to 1914. The emergence of the chemical industry is widely taken as emblematic of the formal research and development taking place at the time. The development of microbiological industries is another example. For the first time, Louis Pasteur’s germ theory made it possible to provide convincing explanations of brewing and other fermentation processes.

Pasteur had published on brewing in the wake of France’s humiliation in the Franco–Prussian war (1870–1871) to assert his country’s superiority in an industry traditionally associated with Germany. Yet the science and technology of fermentation had a wide range of applications including the manufacture of foods (cheese, yogurt, wine, vinegar, and tea), of commodities (tobacco and leather), and of chemicals (lactic acid, citric acid, and the enzyme takaminase). The concept of zymotechnology associated principally with the brewing of beer began to appear too limited to its principal exponents. At the time, Denmark was the world leader in creating high-value agricultural produce. Cooperative farms pioneered intensive pig fattening as well as the mass production of bacon, butter, and beer. It was here that the systems of science and technology were integrated and reintegrated, conceptualized and reconceptualized.

The Dane Emil Christian Hansen discovered that infection from wild yeasts was responsible for numerous failed brews. His contemporary Alfred Jørgensen, a Copenhagen consultant closely associated with the Tuborg brewery, published a widely used textbook on zymotechnology. Microorganisms and Fermentation first appeared in Danish 1889 and would be translated, reedited, and reissued for the next 60 years.

The scarcity of resources on both sides during World War I brought together science and technology, further development of zymotechnology, and formulation of the concept of biotechnology. Impending and then actual war accelerated the use of fermentation technologies to make strategic materials. In Britain a variant of a process to ferment starch to make butadiene for synthetic rubber production was adapted to make acetone needed in the manufacture of explosives. The process was technically important as the first industrial sterile fermentation and was strategically important for munitions supplies. The developer, chemist Chaim Weizmann, later became well known as the first president of Israel in 1949.

In Germany scarce oil-based lubricants were replaced by glycerol made by fermentation. Animal feed was derived from yeast grown with the aid of the new synthetic ammonia in another wartime development that inspired the coining of the word biotechnology. Hungary was the agricultural base of the Austro–Hungarian empire and aspired to Danish levels of efficiency. The economist Karl Ereky (1878–1952) planned to go further and build the largest industrial pig-processing factory. He envisioned a site that would fatten 50,000 swine at a time while railroad cars of sugar beet arrived and fat, hides, and meat departed. In this forerunner of the Soviet collective farm, peasants (in any case now falling prey to the temptations of urban society) would be completely superseded by the industrialization of the biological process in large factory-like animal processing units. Ereky went further in his ruminations over the meaning of his innovation. He suggested that it presaged an industrial revolution that would follow the transformation of chemical technology. In his book entitled Biotechnologie, he linked specific technical injunctions to wide-ranging philosophy. Ereky was neither isolated nor obscure. He had been trained in the mainstream of reflection on the meaning of the applied sciences in Hungary, which would be remarkably productive across the sciences. After World War I, Ereky served as Hungary’s minister of food in the short-lived right wing regime that succeeded the fall of the communist government of Bela Kun.

Nonetheless it was not through Ereky’s direct action that his ideas seem to have spread. Rather, his book was reviewed by the influential Paul Lindner, head of botany at the Institut fu¨ r Ga¨ rungsgewerbe in Berlin, who suggested that microorganisms could also be seen as biotechnological machines. This concept was already found in the production of yeast and in Weizmann’s work with strategic materials, which was widely publicized at that very time. It was with this meaning that the word ‘‘Biotechnologie’’ entered German dictionaries in the 1920s.

Biotechnology represented more than the manipulation of existing organisms. From the beginning it was concerned with their improvement as well, and this meant the enhancement of all living creatures. Most dramatically this would include humanity itself; more mundanely it would include plants and animals of agricultural importance. The enhancement of people was called eugenics by the Victorian polymath and cousin of Charles Darwin, Francis Galton. Two strains of eugenics emerged: negative eugenics associated with weeding out the weak and positive eugenics associated with enhancing strength. In the early twentieth century, many eugenics proponents believed that the weak could be made strong. People had after all progressed beyond their biological limits by means of technology.

Jean-Jacques Virey, a follower of the French naturalist Jean-Baptiste de Monet de Lamarck, had coined the term ‘‘biotechnie’’ in 1828 to describe man’s ability to make technology do the work of biology, but it was not till a century later that the term entered widespread use. The Scottish biologist and town planner Patrick Geddes made biotechnics popular in the English-speaking world. Geddes, too, sought to link life and technology. Before World War I he had characterized the technological evolution of mankind as a move from the paleotechnic era of coal and iron to the neotechnic era of chemicals, electricity, and steel. After the war, he detected a new era based on biology—the biotechnic era. Through his friend, writer Lewis Mumford, Geddes would have great influence. Mumford’s book Technics and Civilization, itself a founding volume of the modern historiography of technology, promoted his vision of the Geddesian evolution.

A younger generation of English experimental biologists with a special interest in genetics, including J. B. S. Haldane, Julian Huxley, and Lancelot Hogben, also promoted a concept of biotechnology in the period between the world wars. Because they wrote popular works, they were among Britain’s best-known scientists. Haldane wrote about biological invention in his far-seeing work Daedalus. Huxley looked forward to a blend of social and eugenics-based biological engineering. Hogben, following Geddes, was more interested in engineering plants through breeding. He tied the progressivism of biology to the advance of socialism.

The improvement of the human race, genetic manipulation of bacteria, and the development of fermentation technology were brought together by the development of penicillin during World War II. This drug was successfully extracted from the juice exuded by a strain of the Penicillium fungus. Although discovered by accident and then developed further for purely scientific reasons, the scarce and unstable ‘‘antibiotic’’ called penicillin was transformed during World War II into a powerful and widely used drug. Large networks of academic and government laboratories and pharmaceutical manufacturers in Britain and the U.S. were coordinated by agencies of the two governments. An unanticipated combination of genetics, biochemistry, chemistry, and chemical engineering skills had been required. When the natural mold was bombarded with high-frequency radiation, far more productive mutants were produced, and subsequently all the medicine was made using the product of these man-made cells. By the 1950s penicillin was cheap to produce and globally available.

The new technology of cultivating and processing large quantities of microorganisms led to calls for a new scientific discipline. Biochemical engineering was one term, and applied microbiology another. The Swedish biologist, Carl-Goran Heden, possibly influenced by German precedents, favored the term ‘‘Biotechnologi’’ and persuaded his friend Elmer Gaden to relabel his new journal Biotechnology and Biochemical Engineering. From 1962 major international conferences were held under the banner of the Global Impact of Applied Microbiology. During the 1960s food based on single-cell protein grown in fermenters on oil or glucose seemed, to visionary engineers and microbiologists and to major companies, to offer an immediate solution to world hunger. Tropical countries rich in biomass that could be used as raw material for fermentation were also the world’s poorest. Alcohol could be manufactured by fermenting such starch or sugar rich crops as sugar cane and corn. Brazil introduced a national program of replacing oil-based petrol with alcohol in the 1970s.

It was not, however, just the developing countries that hoped to benefit. The Soviet Union developed fermentation-based protein as a major source of animal feed through the 1980s. In the U.S. it seemed that oil from surplus corn would solve the problem of low farm prices aggravated by the country’s boycott of the USSR in1979, and the term ‘‘gasohol‘‘ came into currency. Above all, the decline of established industries made the discovery of a new wealth maker an urgent priority for Western governments. Policy makers in both Germany and Japan during the 1970s were driven by a sense of the inadequacy of the last generation of technologies. These were apparently maturing, and the succession was far from clear. Even if electronics or space travel offered routes to the bright industrial future, these fields seemed to be dominated by the U.S. Seeing incipient crisis, the Green, or environmental, movement promoted a technology that would depend on renewable resources and on low-energy processes that would produce biodegradable products, recycle waste, and address problems of the health and nutrition of the world.

In 1973 the German government, seeking a new and ‘‘greener’’ industrial policy, commissioned a report entitled Biotechnologie that identified ways in which biological processing was key to modern developments in technology. Even though the report was published at the time that recombinant DNA (deoxyribonucleic acid) was becoming possible, it did not refer to this new technique and instead focused on the use and combination of existing technologies to make novel products.

Nonetheless the hitherto esoteric science of molecular biology was making considerable progress, although its practice in the early 1970s was rather distant from the world of industrial production. The phrase ‘‘genetic engineering’’ entered common parlance in the 1960s to describe human genetic modification. Medicine, however, put a premium on the use of proteins that were difficult to extract from people: insulin for diabetics and interferon for cancer sufferers. During the early 1970s what had been science fiction became fact as the use of DNA synthesis, restriction enzymes, and plasmids were integrated. In 1973 Stanley Cohen and Herbert Boyer successfully transferred a section of DNA from one E. coli bacterium to another. A few prophets such as Joshua Lederberg and Walter Gilbert argued that the new biological techniques of recombinant DNA might be ideal for making synthetic versions of expensive proteins such as insulin and interferon through their expression in bacterial cells. Small companies, such as Cetus and Genentech in California and Biogen in Cambridge, Massachusetts, were established to develop the techniques. In many cases discoveries made by small ‘‘boutique’’ companies were developed for the market by large, more established, pharmaceutical organizations.

Many governments were impressed by these advances in molecular genetics, which seemed to make biotechnology a potential counterpart to information technology in a third industrial revolution. These inspired hopes of industrial production of proteins identical to those produced in the human body that could be used to treat genetic diseases. There was also hope that industrially useful materials such as alcohol, plastics (biopolymers), or ready-colored fibers might be made in plants, and thus the attractions of a potentially new agricultural era might be as great as the implications for medicine. At a time of concern over low agricultural prices, such hopes were doubly welcome. Indeed, the agricultural benefits sometimes overshadowed the medical implications.

The mechanism for the transfer of enthusiasm from engineering fermenters to engineering genes was the New York Stock Exchange. At the end of the 1970s, new tax laws encouraged already adventurous U.S. investors to put money into small companies whose stock value might grow faster than their profits. The brokerage firm E. F. Hutton saw the potential for the new molecular biology companies such as Biogen and Cetus. Stock market interest in companies promising to make new biological entities was spurred by the 1980 decision of the U.S. Supreme Court to permit the patenting of a new organism. The patent was awarded to the Exxon researcher Ananda Chakrabarty for an organism that metabolized hydrocarbon waste. This event signaled the commercial potential of biotechnology to business and governments around the world. By the early 1980s there were widespread hopes that the protein interferon, made with some novel organism, would provide a cure for cancer. The development of monoclonal antibody technology that grew out of the work of Georges J. F. Kohler and Cesar Milstein in Cambridge (co-recipients with Niels K. Jerne of the Nobel Prize in medicine in 1986) seemed to offer new prospects for precise attacks on particular cells.

The fear of excessive regulatory controls encouraged business and scientific leaders to express optimistic projections about the potential of biotechnology. The early days of biotechnology were fired by hopes of medical products and high-value pharmaceuticals. Human insulin and interferon were early products, and a second generation included the anti-blood clotting agent tPA and the antianemia drug erythropoietin. Biotechnology was also used to help identify potential new drugs that might be made chemically, or synthetically.

At the same time agricultural products were also being developed. Three early products that each raised substantial problems were bacteria which inhibited the formation of frost on the leaves of strawberry plants (ice-minus bacteria), genetically modified plants including tomatoes and rapeseed, and the hormone bovine somatrotropin (BST) produced in genetically modified bacteria and administered to cattle in the U.S. to increase milk yields. By 1999 half the soy beans and one third of the corn grown in the U.S. were modified. Although the global spread of such products would arouse the best known concern at the end of the century, the use of the ice-minus bacteria— the first authorized release of a genetically engineered organism into the environment—had previously raised anxiety in the U.S. in the 1980s.

In 1997 Dolly the sheep was cloned from an adult mother in the Roslin agricultural research institute outside Edinburgh, Scotland. This work was inspired by the need to find a way of reproducing sheep engineered to express human proteins in their milk. However, the public interest was not so much in the cloning of sheep that had just been achieved as in the cloning of people, which had not. As in the Middle Ages when deformed creatures had been seen as monsters and portents of natural disasters, Dolly was similarly seen as monster and as a portent of human cloning.

The name Frankenstein, recalled from the story written by Mary Shelley at the beginning of the nineteenth century and from the movies of the 1930s, was once again familiar at the end of the twentieth century. Shelley had written in the shadow of Stahl’s theories. The continued appeal of this book embodies the continuity of the fears of artificial life and the anxiety over hubris. To this has been linked a more mundane suspicion of the blending of commerce and the exploitation of life. Discussion of biotechnology at the end of the twentieth century was therefore colored by questions of whose assurances of good intent and reassurance of safety could be trusted.

Browse other Technology Research Paper Topics .

ORDER HIGH QUALITY CUSTOM PAPER

• Today's news
• Reviews and deals
• Climate change
• 2024 election
• Fall allergies
• Health news
• Mental health
• Sexual health
• Family health
• So mini ways
• Unapologetically
• Buying guides

Entertainment

• How to Watch
• My Portfolio
• Latest News
• Stock Market
• Biden Economy
• Stocks: Most Actives
• Stocks: Gainers
• Stocks: Losers
• Trending Tickers
• World Indices
• US Treasury Bonds Rates
• Top Mutual Funds
• Options: Highest Open Interest
• Options: Highest Implied Volatility
• Basic Materials
• Communication Services
• Consumer Cyclical
• Consumer Defensive
• Financial Services
• Industrials
• Real Estate
• Stock Comparison
• Advanced Chart
• Currency Converter
• Credit Cards
• Balance Transfer Cards
• Cash-back Cards
• Rewards Cards
• Travel Cards
• Credit Card Offers
• Best Free Checking
• Student Loans
• Personal Loans
• Car insurance
• Mortgage Refinancing
• Mortgage Calculator
• Morning Brief
• Market Domination
• Market Domination Overtime
• Asking for a Trend
• Opening Bid
• Stocks in Translation
• Lead This Way
• Good Buy or Goodbye?
• Financial Freestyle
• Capitol Gains
• Living Not So Fabulously
• Fantasy football
• Pro Pick 'Em
• College Pick 'Em
• Fantasy baseball
• Fantasy hockey
• Fantasy basketball
• Download the app
• Daily fantasy
• Scores and schedules
• GameChannel
• World Baseball Classic
• Premier League
• CONCACAF League
• Champions League
• Motorsports
• Horse racing
• Newsletters

New on Yahoo

• Privacy Dashboard

Yahoo Finance

Global biotechnology industry to witness rapid growth during 2024-2034: prophecy market insights.

The global biotechnology industry is set to witness rapid growth from 2024 to 2034, as per the forecast by Prophecy Market Insights. The biotechnology industry is experiencing rapid growth, driven by advances in technology, an aging population, and increasing demand for quality care. Innovations in telemedicine, AI, and personalized medicine are transforming patient care, while global health challenges highlight the need for robust healthcare systems.

Covina, Aug. 23, 2024 (GLOBE NEWSWIRE) -- According to estimations by Prophecy Market Insights, the global biotechnology sector is expected to develop significantly between 2024 and 2034. Developments in genetic engineering and customised medicine have been major forces behind the biotechnology industry's growth. The demand has been further accelerated by growing awareness of biotechnology's potential to address environmental sustainability and global health challenges; this trend is anticipated to continue throughout the forecast period.

The following are some of the major markets that have an impact on the industry completely:

Omics-Based Clinical Trials Market size was USD 31.5 billion in 2024 and is projected to grow at a CAGR of 8.9% from 2024 to 2034. The requirement for individualised treatment plans is propelling the growing use of precision medicine, which is contributing significantly to the expansion of omics-based clinical trials.

MedTech CMO Market size was USD 61.3 billion in 2024 and is anticipated to grow at a compound annual growth rate (CAGR) of 5.0% from 2024 to 2034. The primary force behind the growth of the target market is the growing necessity for outsourcing in the production of medical devices due to the need for specialised knowledge and cost effectiveness.

Cell and Gene Therapy CDMO Market size was USD 4.4 billion in 2024 globally and is anticipated to grow at a compound annual growth rate (CAGR) of 28.90% from 2024 to 2034. The surge in the development of advanced therapies, coupled with increasing investments in cell and gene therapy research, is driving the growth of the target market.

Biologics CDMO Market size was USD 18 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 11.80% from 2024 to 2034. One of the main factors boosting the target market is the expanding pipeline of biologic medications, which is being pushed by the rising incidence of chronic illnesses and the need for novel treatments.

CAR-T Cell Therapy Market size was USD 2.7 billion in 2024 globally and is anticipated to rise at a compound annual growth rate (CAGR) of 1.80% from 2024 to 2034. The key drivers of this market are the notable progress made in immunotherapy and the growing number of CAR-T cell treatments that have received FDA approval.

U.S Cell and Gene Therapy CDMO Market size was USD 2.37 billion in 2024 and is expected to grow at a compound annual growth rate (CAGR) of 28.90% from 2024 to 2034. The strong regulatory environment and growing governmental backing for advancements in gene and cell therapy are major factors propelling the U.S. market for CDMOs in these fields.

GLP-1 Analogues Market size was USD 45.3 billion in 2024 globally and is expected to grow at a compound annual growth rate (CAGR) 33% from 2024 to 2034. The target market is expanding as a result of the growing incidence of diabetes and obesity as well as the demonstrated effectiveness of GLP-1 mimics in treating these illnesses.

Brain Health Supplements Market size was USD 9.94 billion in 2024 and is expected to grow at a compound annual growth rate (CAGR) of 9.7% from 2024 to 2034. The increasing global aging population is driving the demand for brain health supplements as individuals seek to maintain cognitive function and prevent age-related mental decline.

Cancer Immunotherapy Market size was USD 158.5 billion in 2024 and is expected to grow at a compound annual growth rate (CAGR) of 14.2% from 2024 to 2034. The increasing prevalence of various types of cancer worldwide is boosting the demand for immunotherapy as an alternative or complementary treatment to traditional cancer therapies like chemotherapy and radiation.

Tumor-Infiltrating Lymphocyte (TIL) Therapy Market size was USD 0.1 billion in 2024 and is expected to grow at a compound annual growth rate (CAGR) of 40% from 2024 to 2034. The market for tumor-infiltrating lymphocyte (TIL) therapy is expanding due to encouraging clinical results and rising funding for cancer immunotherapy research.

Prophecy Market Insights is a specialized market research, analytics, marketing and business strategy, and solutions company that offer strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high value opportunities in the target business area. Also, we help our client to address business challenges and provide best possible solutions to overcome them and transform their business.

Prophecy’s expertize area covers products, services, latest trends, developments, market growth factors, and challenges along with market forecast in various business areas such as Healthcare, Pharmaceutical, Biotechnology, Information Technology (IT), Automotive, Industrial, Chemical, Agriculture, Food and Beverage, Energy, and Oil and Gas. We also offer various other services such as, data mining, information management, and revenue enhancement suggestions.

Contact Us:

Prophecy Market Insights

US: 964 E. Badillo Street

#2042 Covina,

US toll-free: +1 860 531 2574

Rest of World: + 91 7775049802

Follow us on  LinkedIn  |  Twitter